ONTOLOGY REPORT - ANNOTATIONS
| Term: | 2,3,7,8-tetrachlorodibenzodioxine |
|
| Accession: | CHEBI:28119
|
browse the term
|
| Definition: | A polychlorinated dibenzodioxine that has formula C12H4Cl4O2. |
| Synonyms: | exact_synonym: | 2,3,7,8-tetrachlorooxanthrene |
| | related_synonym: | 2,3,7,8-Tetrachlorodibenzo-p-dioxin; 2,3,7,8-Tetrachlorodibenzodioxin; C12H4Cl4O2; Clc1cc2Oc3cc(Cl)c(Cl)cc3Oc2cc1Cl; Dioxin; InChI=1S/C12H4Cl4O2/c13-5-1-9-10(2-6(5)14)18-12-4-8(16)7(15)3-11(12)17-9/h1-4H; InChIKey=HGUFODBRKLSHSI-UHFFFAOYSA-N; TCDD; Tetrachlorodibenzodioxin; dioxine; tetradioxin |
| | alt_id: | CHEBI:19302; CHEBI:869 |
| | xref_casrn: | 1746-01-6 |
| | xref: | Beilstein:271116 "Beilstein Registry Number"; ChEMBL:143756 "ChEMBL COMPOUND"; ChemIDplus:1746-01-6 "CAS Registry Number"; Gmelin:366537 "Gmelin Registry Number"; KEGG COMPOUND:1746-01-6 "CAS Registry Number"; KEGG COMPOUND:C07557 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D013749 |
| | xref: | NIST Chemistry WebBook:1746-01-6 "CAS Registry Number"; Wikipedia:2\,3\,7\,8-Tetrachlorodibenzo-P-Dioxin "Wikipedia" |
|
|
2,3,7,8-tetrachlorodibenzodioxine
|
| G |
AAED1 |
AhpC/TSA antioxidant enzyme domain containing 1 |
|
increases expression |
EXP |
9 |
99,403,533 |
99,417,599 |
RGD:6480464 |
CTD |
| G |
ABRACL |
ABRA C-terminal like |
|
increases expression |
EXP |
6 |
139,349,819 |
139,364,439 |
RGD:6480464 |
CTD |
| G |
ACYP2 |
acylphosphatase 2, muscle type |
|
multiple interactions |
ISO |
2 |
54,342,410 |
54,532,437 |
RGD:6480464 |
CTD |
| G |
ADAT2 |
adenosine deaminase, tRNA-specific 2 |
|
multiple interactions |
ISO |
6 |
143,743,969 |
143,771,841 |
RGD:6480464 |
CTD |
| G |
ADIRF |
adipogenesis regulatory factor |
|
decreases expression |
EXP |
10 |
88,728,188 |
88,730,666 |
RGD:6480464 |
CTD |
| G |
AGO4 |
argonaute RISC catalytic component 4 |
|
affects expression |
ISO |
1 |
36,273,828 |
36,323,491 |
RGD:6480464 |
CTD |
| G |
ALPPL2 |
alkaline phosphatase, placental-like 2 |
|
multiple interactions |
ISO |
2 |
233,271,552 |
233,275,424 |
RGD:6480464 |
CTD |
| G |
ANKHD1 |
ankyrin repeat and KH domain containing 1 |
|
decreases expression |
ISO |
5 |
139,781,399 |
139,919,441 |
RGD:6480464 |
CTD |
| G |
ANTXR2 |
anthrax toxin receptor 2 |
|
multiple interactions |
ISO |
4 |
80,822,771 |
80,994,477 |
RGD:6480464 |
CTD |
| G |
ANTXR2 |
anthrax toxin receptor 2 |
|
multiple interactions |
ISO |
4 |
80,822,771 |
80,994,477 |
RGD:6480464 |
CTD |
| G |
ANTXR2 |
anthrax toxin receptor 2 |
|
multiple interactions |
ISO |
4 |
80,822,771 |
80,994,477 |
RGD:6480464 |
CTD |
| G |
ANTXR2 |
anthrax toxin receptor 2 |
|
increases expression |
ISO |
4 |
80,822,771 |
80,994,477 |
RGD:6480464 |
CTD |
| G |
ARHGEF28 |
Rho guanine nucleotide exchange factor (GEF) 28 |
|
increases expression |
ISO |
5 |
72,921,983 |
73,237,818 |
RGD:6480464 |
CTD |
| G |
ARL14EP |
ADP-ribosylation factor-like 14 effector protein |
|
decreases expression |
EXP |
11 |
30,344,649 |
30,359,165 |
RGD:6480464 |
CTD |
| G |
ARPC1A |
actin related protein 2/3 complex, subunit 1A, 41kDa |
|
increases expression |
ISO |
7 |
98,923,496 |
98,963,885 |
RGD:6480464 |
CTD |
| G |
AXL |
AXL receptor tyrosine kinase |
|
increases expression |
EXP |
19 |
41,725,108 |
41,767,671 |
RGD:6480464 |
CTD |
| G |
AZGP1 |
alpha-2-glycoprotein 1, zinc-binding |
|
multiple interactions |
ISO |
7 |
99,564,350 |
99,573,735 |
RGD:6480464 |
CTD |
| G |
AZGP1 |
alpha-2-glycoprotein 1, zinc-binding |
|
decreases expression |
ISO |
7 |
99,564,350 |
99,573,735 |
RGD:6480464 |
CTD |
| G |
AZI2 |
5-azacytidine induced 2 |
|
multiple interactions |
ISO |
3 |
28,363,845 |
28,390,618 |
RGD:6480464 |
CTD |
| G |
B2M |
beta-2-microglobulin |
|
increases expression |
EXP |
15 |
45,003,685 |
45,010,357 |
RGD:6480464 |
CTD |
| G |
B2M |
beta-2-microglobulin |
|
decreases expression |
ISO |
15 |
45,003,685 |
45,010,357 |
RGD:6480464 |
CTD |
| G |
B2M |
beta-2-microglobulin |
|
decreases expression |
ISO |
15 |
45,003,685 |
45,010,357 |
RGD:6480464 |
CTD |
| G |
B3GALNT2 |
beta-1,3-N-acetylgalactosaminyltransferase 2 |
|
increases expression |
ISO |
1 |
235,610,533 |
235,667,781 |
RGD:6480464 |
CTD |
| G |
B3GALT2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
|
increases expression |
ISO |
1 |
193,147,860 |
193,155,743 |
RGD:6480464 |
CTD |
| G |
B3GNT1 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 |
|
multiple interactions |
ISO |
11 |
66,112,843 |
66,115,161 |
RGD:6480464 |
CTD |
| G |
B3GNT5 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
|
decreases expression |
EXP |
3 |
182,971,032 |
182,991,179 |
RGD:6480464 |
CTD |
| G |
B3GNT7 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 |
|
multiple interactions |
ISO |
2 |
232,260,335 |
232,265,875 |
RGD:6480464 |
CTD |
| G |
B4GALNT1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
|
multiple interactions |
ISO |
12 |
58,019,551 |
58,026,985 |
RGD:6480464 |
CTD |
| G |
B4GALNT1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
|
decreases expression |
ISO |
12 |
58,019,551 |
58,026,985 |
RGD:6480464 |
CTD |
| G |
B4GALT1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
|
increases expression |
EXP |
9 |
33,110,639 |
33,167,356 |
RGD:6480464 |
CTD |
| G |
B4GALT6 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6 |
|
decreases expression |
ISO |
18 |
29,202,209 |
29,264,686 |
RGD:6480464 |
CTD |
| G |
B9D1 |
B9 protein domain 1 |
|
multiple interactions |
ISO |
17 |
19,240,867 |
19,281,495 |
RGD:6480464 |
CTD |
| G |
BAAT |
bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) |
|
decreases expression |
EXP |
9 |
104,122,699 |
104,147,287 |
RGD:6480464 |
CTD |
| G |
BACH1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
|
decreases expression |
EXP |
21 |
30,671,220 |
30,734,217 |
RGD:6480464 |
CTD |
| G |
BACH1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
|
increases expression |
ISO |
21 |
30,671,220 |
30,734,217 |
RGD:6480464 |
CTD |
| G |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
multiple interactions |
ISO |
6 |
90,636,247 |
91,006,627 |
RGD:6480464 |
CTD |
| G |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
increases expression |
ISO |
6 |
90,636,247 |
91,006,627 |
RGD:6480464 |
CTD |
| G |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
multiple interactions |
ISO |
6 |
90,636,247 |
91,006,627 |
RGD:6480464 |
CTD |
| G |
BAD |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
11 |
64,037,300 |
64,052,176 |
RGD:6480464 |
CTD |
| G |
BAD |
BCL2-associated agonist of cell death |
|
increases expression |
ISO |
11 |
64,037,300 |
64,052,176 |
RGD:6480464 |
CTD |
| G |
BAG3 |
BCL2-associated athanogene 3 |
|
multiple interactions |
ISO |
10 |
121,410,882 |
121,437,331 |
RGD:6480464 |
CTD |
| G |
BAI2 |
brain-specific angiogenesis inhibitor 2 |
|
multiple interactions |
ISO |
1 |
32,192,718 |
32,229,648 |
RGD:6480464 |
CTD |
| G |
BAIAP2 |
BAI1-associated protein 2 |
|
multiple interactions |
ISO |
17 |
79,008,947 |
79,091,232 |
RGD:6480464 |
CTD |
| G |
BAIAP2L1 |
BAI1-associated protein 2-like 1 |
|
decreases expression |
ISO |
7 |
97,920,962 |
98,030,427 |
RGD:6480464 |
CTD |
| G |
BAIAP2L1 |
BAI1-associated protein 2-like 1 |
|
increases expression |
ISO |
7 |
97,920,962 |
98,030,427 |
RGD:6480464 |
CTD |
| G |
BAIAP2L1 |
BAI1-associated protein 2-like 1 |
|
multiple interactions |
ISO |
7 |
97,920,962 |
98,030,427 |
RGD:6480464 |
CTD |
| G |
BAK1 |
BCL2-antagonist/killer 1 |
|
increases expression |
ISO |
6 |
33,540,323 |
33,548,070 |
RGD:6480464 |
CTD |
| G |
BAMBI |
BMP and activin membrane-bound inhibitor homolog (Xenopus laevis) |
|
multiple interactions |
EXP |
10 |
28,966,424 |
28,971,868 |
RGD:6480464 |
CTD |
| G |
BAMBI |
BMP and activin membrane-bound inhibitor homolog (Xenopus laevis) |
|
increases expression |
EXP |
10 |
28,966,424 |
28,971,868 |
RGD:6480464 |
CTD |
| G |
BANF1 |
barrier to autointegration factor 1 |
|
multiple interactions |
ISO |
11 |
65,769,550 |
65,771,617 |
RGD:6480464 |
CTD |
| G |
BANK1 |
B-cell scaffold protein with ankyrin repeats 1 |
|
multiple interactions |
ISO |
4 |
102,711,764 |
102,995,969 |
RGD:6480464 |
CTD |
| G |
BANK1 |
B-cell scaffold protein with ankyrin repeats 1 |
|
decreases expression |
ISO |
4 |
102,711,764 |
102,995,969 |
RGD:6480464 |
CTD |
| G |
BCL6B |
B-cell CLL/lymphoma 6, member B |
|
increases expression |
ISO |
17 |
6,926,369 |
6,932,961 |
RGD:6480464 |
CTD |
| G |
BCL6B |
B-cell CLL/lymphoma 6, member B |
|
multiple interactions |
ISO |
17 |
6,926,369 |
6,932,961 |
RGD:6480464 |
CTD |
| G |
BCL7A |
B-cell CLL/lymphoma 7A |
|
decreases expression |
EXP |
12 |
122,459,861 |
122,499,950 |
RGD:6480464 |
CTD |
| G |
BCL7C |
B-cell CLL/lymphoma 7C |
|
increases methylation |
ISO |
16 |
30,899,116 |
30,905,399 |
RGD:6480464 |
CTD |
| G |
BCL9 |
B-cell CLL/lymphoma 9 |
|
increases expression |
ISO |
1 |
147,013,182 |
147,098,017 |
RGD:6480464 |
CTD |
| G |
BCLAF1 |
BCL2-associated transcription factor 1 |
|
increases expression |
ISO |
6 |
136,578,001 |
136,610,989 |
RGD:6480464 |
CTD |
| G |
BCLAF1 |
BCL2-associated transcription factor 1 |
|
multiple interactions |
ISO |
6 |
136,578,001 |
136,610,989 |
RGD:6480464 |
CTD |
| G |
BCO2 |
beta-carotene oxygenase 2 |
|
decreases expression |
EXP |
11 |
112,046,208 |
112,089,652 |
RGD:6480464 |
CTD |
| G |
BCR |
breakpoint cluster region |
|
increases expression |
EXP |
22 |
23,522,552 |
23,660,224 |
RGD:6480464 |
CTD |
| G |
BCS1L |
BC1 (ubiquinol-cytochrome c reductase) synthesis-like |
|
multiple interactions |
ISO |
2 |
219,524,379 |
219,528,166 |
RGD:6480464 |
CTD |
| G |
BCS1L |
BC1 (ubiquinol-cytochrome c reductase) synthesis-like |
|
increases expression |
ISO |
2 |
219,524,379 |
219,528,166 |
RGD:6480464 |
CTD |
| G |
BDH1 |
3-hydroxybutyrate dehydrogenase, type 1 |
|
multiple interactions |
EXP |
3 |
197,236,654 |
197,300,194 |
RGD:6480464 |
CTD |
| G |
BDH1 |
3-hydroxybutyrate dehydrogenase, type 1 |
|
decreases expression |
EXP |
3 |
197,236,654 |
197,300,194 |
RGD:6480464 |
CTD |
| G |
BDH1 |
3-hydroxybutyrate dehydrogenase, type 1 |
|
decreases expression |
ISO |
3 |
197,236,654 |
197,300,194 |
RGD:6480464 |
CTD |
| G |
BDKRB2 |
bradykinin receptor B2 |
|
multiple interactions |
EXP |
14 |
96,671,135 |
96,710,666 |
RGD:6480464 |
CTD |
| G |
BDKRB2 |
bradykinin receptor B2 |
|
decreases expression |
EXP |
14 |
96,671,135 |
96,710,666 |
RGD:6480464 |
CTD |
| G |
BDKRB2 |
bradykinin receptor B2 |
|
increases expression |
EXP |
14 |
96,671,135 |
96,710,666 |
RGD:6480464 |
CTD |
| G |
BDNF |
brain-derived neurotrophic factor |
|
increases expression |
ISO |
11 |
27,676,440 |
27,743,605 |
RGD:6480464 |
CTD |
| G |
BDNF |
brain-derived neurotrophic factor |
|
affects expression |
ISO |
11 |
27,676,440 |
27,743,605 |
RGD:6480464 |
CTD |
| G |
BECN1 |
beclin 1, autophagy related |
|
multiple interactions |
ISO |
17 |
40,962,150 |
40,976,310 |
RGD:6480464 |
CTD |
| G |
BET1 |
Bet1 golgi vesicular membrane trafficking protein |
|
multiple interactions |
ISO |
7 |
93,621,000 |
93,633,690 |
RGD:6480464 |
CTD |
| G |
BET1L |
Bet1 golgi vesicular membrane trafficking protein-like |
|
multiple interactions |
ISO |
11 |
202,924 |
207,422 |
RGD:6480464 |
CTD |
| G |
BET1L |
Bet1 golgi vesicular membrane trafficking protein-like |
|
increases expression |
ISO |
11 |
202,924 |
207,422 |
RGD:6480464 |
CTD |
| G |
BEX1 |
brain expressed, X-linked 1 |
|
multiple interactions |
ISO |
X |
102,317,581 |
102,319,168 |
RGD:6480464 |
CTD |
| G |
BFSP2 |
beaded filament structural protein 2, phakinin |
|
multiple interactions |
EXP |
3 |
133,118,790 |
133,194,056 |
RGD:6480464 |
CTD |
| G |
BFSP2 |
beaded filament structural protein 2, phakinin |
|
increases expression |
EXP |
3 |
133,118,790 |
133,194,056 |
RGD:6480464 |
CTD |
| G |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
1 |
156,211,951 |
156,213,123 |
RGD:6480464 |
CTD |
| G |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
|
decreases expression |
ISO |
1 |
156,211,951 |
156,213,123 |
RGD:6480464 |
CTD |
| G |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
|
decreases expression |
ISO |
1 |
156,211,951 |
156,213,123 |
RGD:6480464 |
CTD |
| G |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
|
decreases expression |
ISO |
1 |
156,211,951 |
156,213,123 |
RGD:6480464 |
CTD |
| G |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
|
decreases expression |
ISO |
1 |
156,211,951 |
156,213,123 |
RGD:6480464 |
CTD |
| G |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
|
multiple interactions |
ISO |
1 |
156,211,951 |
156,213,123 |
RGD:6480464 |
CTD |
| G |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
|
decreases expression |
ISO |
1 |
156,211,951 |
156,213,123 |
RGD:6480464 |
CTD |
| G |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
|
decreases expression |
ISO |
1 |
156,211,951 |
156,213,123 |
RGD:6480464 |
CTD |
| G |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
|
decreases expression |
ISO |
1 |
156,211,951 |
156,213,123 |
RGD:6480464 |
CTD |
| G |
BGN |
biglycan |
|
decreases expression |
ISO |
X |
152,760,347 |
152,775,004 |
RGD:6480464 |
CTD |
| G |
BGN |
biglycan |
|
increases expression |
ISO |
X |
152,760,347 |
152,775,004 |
RGD:6480464 |
CTD |
| G |
BHLHA15 |
basic helix-loop-helix family, member a15 |
|
multiple interactions |
ISO |
7 |
97,841,566 |
97,842,271 |
RGD:6480464 |
CTD |
| G |
BHLHA15 |
basic helix-loop-helix family, member a15 |
|
increases expression |
ISO |
7 |
97,841,566 |
97,842,271 |
RGD:6480464 |
CTD |
| G |
BHLHE40 |
basic helix-loop-helix family, member e40 |
|
decreases expression |
EXP |
3 |
5,021,097 |
5,026,866 |
RGD:6480464 |
CTD |
| G |
BHLHE40 |
basic helix-loop-helix family, member e40 |
|
decreases expression |
ISO |
3 |
5,021,097 |
5,026,866 |
RGD:6480464 |
CTD |
| G |
BHLHE40 |
basic helix-loop-helix family, member e40 |
|
increases expression |
ISO |
3 |
5,021,097 |
5,026,866 |
RGD:6480464 |
CTD |
| G |
BHLHE40 |
basic helix-loop-helix family, member e40 |
|
increases expression |
ISO |
3 |
5,021,097 |
5,026,866 |
RGD:6480464 |
CTD |
| G |
BHMT |
betaine--homocysteine S-methyltransferase |
|
decreases expression |
ISO |
5 |
78,407,604 |
78,428,113 |
RGD:6480464 |
CTD |
| G |
BHMT |
betaine--homocysteine S-methyltransferase |
|
increases expression |
ISO |
5 |
78,407,604 |
78,428,113 |
RGD:6480464 |
CTD |
| G |
BHMT2 |
betaine--homocysteine S-methyltransferase 2 |
|
multiple interactions |
ISO |
5 |
78,365,547 |
78,385,897 |
RGD:6480464 |
CTD |
| G |
BHMT2 |
betaine--homocysteine S-methyltransferase 2 |
|
increases expression |
ISO |
5 |
78,365,547 |
78,385,897 |
RGD:6480464 |
CTD |
| G |
BICC1 |
bicaudal C homolog 1 (Drosophila) |
|
increases expression |
EXP |
10 |
60,272,904 |
60,588,845 |
RGD:6480464 |
CTD |
| G |
BICD2 |
bicaudal D homolog 2 (Drosophila) |
|
increases expression |
EXP |
9 |
95,473,645 |
95,527,083 |
RGD:6480464 |
CTD |
| G |
BICD2 |
bicaudal D homolog 2 (Drosophila) |
|
increases expression |
ISO |
9 |
95,473,645 |
95,527,083 |
RGD:6480464 |
CTD |
| G |
BICD2 |
bicaudal D homolog 2 (Drosophila) |
|
multiple interactions |
ISO |
9 |
95,473,645 |
95,527,083 |
RGD:6480464 |
CTD |
| G |
BID |
BH3 interacting domain death agonist |
|
increases cleavage |
ISO |
22 |
18,216,906 |
18,257,431 |
RGD:6480464 |
CTD |
| G |
BID |
BH3 interacting domain death agonist |
|
increases expression |
ISO |
22 |
18,216,906 |
18,257,431 |
RGD:6480464 |
CTD |
| G |
BIK |
BCL2-interacting killer (apoptosis-inducing) |
|
decreases expression |
EXP |
22 |
43,506,754 |
43,525,718 |
RGD:6480464 |
CTD |
| G |
BIK |
BCL2-interacting killer (apoptosis-inducing) |
|
increases expression |
EXP |
22 |
43,506,754 |
43,525,718 |
RGD:6480464 |
CTD |
| G |
BIK |
BCL2-interacting killer (apoptosis-inducing) |
|
affects expression |
ISO |
22 |
43,506,754 |
43,525,718 |
RGD:6480464 |
CTD |
| G |
BIK |
BCL2-interacting killer (apoptosis-inducing) |
|
multiple interactions |
EXP |
22 |
43,506,754 |
43,525,718 |
RGD:6480464 |
CTD |
| G |
BIK |
BCL2-interacting killer (apoptosis-inducing) |
|
increases expression |
ISO |
22 |
43,506,754 |
43,525,718 |
RGD:6480464 |
CTD |
| G |
BIN3 |
bridging integrator 3 |
|
multiple interactions |
ISO |
8 |
22,477,931 |
22,526,661 |
RGD:6480464 |
CTD |
| G |
BIRC2 |
baculoviral IAP repeat containing 2 |
|
increases expression |
ISO |
11 |
102,217,913 |
102,249,401 |
RGD:6480464 |
CTD |
| G |
BIRC3 |
baculoviral IAP repeat containing 3 |
|
increases expression |
EXP |
11 |
102,188,181 |
102,210,134 |
RGD:6480464 |
CTD |
| G |
BIRC3 |
baculoviral IAP repeat containing 3 |
|
increases expression |
ISO |
11 |
102,188,181 |
102,210,134 |
RGD:6480464 |
CTD |
| G |
BIRC3 |
baculoviral IAP repeat containing 3 |
|
multiple interactions |
ISO |
11 |
102,188,181 |
102,210,134 |
RGD:6480464 |
CTD |
| G |
BIRC3 |
baculoviral IAP repeat containing 3 |
|
increases expression |
ISO |
11 |
102,188,181 |
102,210,134 |
RGD:6480464 |
CTD |
| G |
BIRC5 |
baculoviral IAP repeat containing 5 |
|
multiple interactions |
ISO |
17 |
76,210,277 |
76,221,716 |
RGD:6480464 |
CTD |
| G |
BIRC5 |
baculoviral IAP repeat containing 5 |
|
increases expression |
ISO |
17 |
76,210,277 |
76,221,716 |
RGD:6480464 |
CTD |
| G |
BIRC6 |
baculoviral IAP repeat containing 6 |
|
decreases expression |
ISO |
2 |
32,582,096 |
32,843,966 |
RGD:6480464 |
CTD |
| G |
BLCAP |
bladder cancer associated protein |
|
multiple interactions |
ISO |
20 |
36,145,819 |
36,156,333 |
RGD:6480464 |
CTD |
| G |
BRCA2 |
breast cancer 2, early onset |
|
increases expression |
ISO |
13 |
32,889,617 |
32,973,809 |
RGD:6480464 |
CTD |
| G |
BRCC3 |
BRCA1/BRCA2-containing complex, subunit 3 |
|
increases expression |
ISO |
X |
154,299,695 |
154,351,349 |
RGD:6480464 |
CTD |
| G |
BRD2 |
bromodomain containing 2 |
|
multiple interactions |
EXP |
6 |
32,936,437 |
32,949,282 |
RGD:6480464 |
CTD |
| G |
BRD2 |
bromodomain containing 2 |
|
affects expression |
ISO |
6 |
32,936,437 |
32,949,282 |
RGD:6480464 |
CTD |
| G |
BRD3 |
bromodomain containing 3 |
|
multiple interactions |
ISO |
9 |
136,895,427 |
136,933,141 |
RGD:6480464 |
CTD |
| G |
BRD7 |
bromodomain containing 7 |
|
multiple interactions |
ISO |
16 |
50,352,929 |
50,402,845 |
RGD:6480464 |
CTD |
| G |
BRD8 |
bromodomain containing 8 |
|
multiple interactions |
ISO |
5 |
137,475,459 |
137,514,358 |
RGD:6480464 |
CTD |
| G |
BRE |
brain and reproductive organ-expressed (TNFRSF1A modulator) |
|
increases expression |
ISO |
2 |
28,113,482 |
28,561,768 |
RGD:6480464 |
CTD |
| G |
BRE |
brain and reproductive organ-expressed (TNFRSF1A modulator) |
|
increases expression |
ISO |
2 |
28,113,482 |
28,561,768 |
RGD:6480464 |
CTD |
| G |
BRF1 |
BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae) |
|
multiple interactions |
ISO |
14 |
105,675,623 |
105,781,914 |
RGD:6480464 |
CTD |
| G |
BRI3 |
brain protein I3 |
|
decreases expression |
ISO |
7 |
97,910,979 |
97,922,275 |
RGD:6480464 |
CTD |
| G |
BRI3BP |
BRI3 binding protein |
|
multiple interactions |
ISO |
12 |
125,478,194 |
125,510,349 |
RGD:6480464 |
CTD |
| G |
BRIP1 |
BRCA1 interacting protein C-terminal helicase 1 |
|
decreases expression |
EXP |
17 |
59,756,547 |
59,940,920 |
RGD:6480464 |
CTD |
| G |
BRIX1 |
BRX1, biogenesis of ribosomes, homolog (S. cerevisiae) |
|
decreases expression |
EXP |
5 |
34,915,820 |
34,925,787 |
RGD:6480464 |
CTD |
| G |
BRMS1 |
breast cancer metastasis suppressor 1 |
|
multiple interactions |
ISO |
11 |
66,104,804 |
66,112,582 |
RGD:6480464 |
CTD |
| G |
BRPF1 |
bromodomain and PHD finger containing, 1 |
|
multiple interactions |
ISO |
3 |
9,773,434 |
9,789,699 |
RGD:6480464 |
CTD |
| G |
BSN |
bassoon presynaptic cytomatrix protein |
|
increases expression |
ISO |
3 |
49,591,922 |
49,708,982 |
RGD:6480464 |
CTD |
| G |
BST1 |
bone marrow stromal cell antigen 1 |
|
decreases expression |
EXP |
4 |
15,704,573 |
15,733,796 |
RGD:6480464 |
CTD |
| G |
BST1 |
bone marrow stromal cell antigen 1 |
|
multiple interactions |
ISO |
4 |
15,704,573 |
15,733,796 |
RGD:6480464 |
CTD |
| G |
BST1 |
bone marrow stromal cell antigen 1 |
|
increases expression |
ISO |
4 |
15,704,573 |
15,733,796 |
RGD:6480464 |
CTD |
| G |
BST2 |
bone marrow stromal cell antigen 2 |
|
multiple interactions |
EXP |
19 |
17,513,755 |
17,516,384 |
RGD:6480464 |
CTD |
| G |
BST2 |
bone marrow stromal cell antigen 2 |
|
increases expression |
EXP |
19 |
17,513,755 |
17,516,384 |
RGD:6480464 |
CTD |
| G |
BST2 |
bone marrow stromal cell antigen 2 |
|
decreases expression |
EXP |
19 |
17,513,755 |
17,516,384 |
RGD:6480464 |
CTD |
| G |
BTAF1 |
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae) |
|
increases expression |
ISO |
10 |
93,683,736 |
93,790,082 |
RGD:6480464 |
CTD |
| G |
BTBD11 |
BTB (POZ) domain containing 11 |
|
decreases expression |
EXP |
12 |
107,712,197 |
108,053,419 |
RGD:6480464 |
CTD |
| G |
BTBD11 |
BTB (POZ) domain containing 11 |
|
increases expression |
ISO |
12 |
107,712,197 |
108,053,419 |
RGD:6480464 |
CTD |
| G |
BTBD11 |
BTB (POZ) domain containing 11 |
|
multiple interactions |
ISO |
12 |
107,712,197 |
108,053,419 |
RGD:6480464 |
CTD |
| G |
BTBD6 |
BTB (POZ) domain containing 6 |
|
decreases expression |
ISO |
14 |
105,714,879 |
105,717,430 |
RGD:6480464 |
CTD |
| G |
BTBD9 |
BTB (POZ) domain containing 9 |
|
multiple interactions |
ISO |
6 |
38,136,227 |
38,607,924 |
RGD:6480464 |
CTD |
| G |
BTC |
betacellulin |
|
decreases expression |
ISO |
4 |
75,671,448 |
75,719,882 |
RGD:6480464 |
CTD |
| G |
BTF3 |
basic transcription factor 3 |
|
affects expression |
ISO |
5 |
72,794,250 |
72,801,448 |
RGD:6480464 |
CTD |
| G |
BTF3L4 |
basic transcription factor 3-like 4 |
|
increases expression |
ISO |
1 |
52,521,857 |
52,556,388 |
RGD:6480464 |
CTD |
| G |
BTG1 |
B-cell translocation gene 1, anti-proliferative |
|
multiple interactions |
ISO |
12 |
92,534,054 |
92,539,673 |
RGD:6480464 |
CTD |
| G |
BTG1 |
B-cell translocation gene 1, anti-proliferative |
|
increases expression |
ISO |
12 |
92,534,054 |
92,539,673 |
RGD:6480464 |
CTD |
| G |
BTG1 |
B-cell translocation gene 1, anti-proliferative |
|
increases expression |
ISO |
12 |
92,534,054 |
92,539,673 |
RGD:6480464 |
CTD |
| G |
BTG2 |
BTG family, member 2 |
|
multiple interactions |
ISO |
1 |
203,274,664 |
203,278,730 |
RGD:6480464 |
CTD |
| G |
BTG2 |
BTG family, member 2 |
|
affects expression |
ISO |
1 |
203,274,664 |
203,278,730 |
RGD:6480464 |
CTD |
| G |
BTG2 |
BTG family, member 2 |
|
increases expression |
ISO |
1 |
203,274,664 |
203,278,730 |
RGD:6480464 |
CTD |
| G |
BTG4 |
B-cell translocation gene 4 |
|
multiple interactions |
ISO |
11 |
111,338,255 |
111,383,079 |
RGD:6480464 |
CTD |
| G |
BTK |
Bruton agammaglobulinemia tyrosine kinase |
|
multiple interactions |
ISO |
X |
100,604,435 |
100,641,212 |
RGD:6480464 |
CTD |
| G |
BTNL8 |
butyrophilin-like 8 |
|
decreases expression |
EXP |
5 |
180,326,077 |
180,377,906 |
RGD:6480464 |
CTD |
| G |
BUB1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
multiple interactions |
ISO |
2 |
111,395,409 |
111,435,684 |
RGD:6480464 |
CTD |
| G |
BUB1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
increases expression |
ISO |
2 |
111,395,409 |
111,435,684 |
RGD:6480464 |
CTD |
| G |
BUB1B |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
multiple interactions |
ISO |
15 |
40,453,210 |
40,513,337 |
RGD:6480464 |
CTD |
| G |
BUD31 |
BUD31 homolog (S. cerevisiae) |
|
affects expression |
ISO |
7 |
99,006,601 |
99,017,239 |
RGD:6480464 |
CTD |
| G |
BUD31 |
BUD31 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
7 |
99,006,601 |
99,017,239 |
RGD:6480464 |
CTD |
| G |
BYSL |
bystin-like |
|
multiple interactions |
ISO |
6 |
41,888,965 |
41,900,784 |
RGD:6480464 |
CTD |
| G |
BYSL |
bystin-like |
|
increases expression |
ISO |
6 |
41,888,965 |
41,900,784 |
RGD:6480464 |
CTD |
| G |
BZW1 |
basic leucine zipper and W2 domains 1 |
|
multiple interactions |
ISO |
2 |
201,676,269 |
201,688,569 |
RGD:6480464 |
CTD |
| G |
C11orf24 |
chromosome 11 open reading frame 24 |
|
increases expression |
EXP |
11 |
68,028,803 |
68,039,469 |
RGD:6480464 |
CTD |
| G |
C11orf24 |
chromosome 11 open reading frame 24 |
|
decreases expression |
ISO |
11 |
68,028,803 |
68,039,469 |
RGD:6480464 |
CTD |
| G |
C12orf23 |
chromosome 12 open reading frame 23 |
|
multiple interactions |
EXP |
12 |
107,349,544 |
107,367,813 |
RGD:6480464 |
CTD |
| G |
C12orf23 |
chromosome 12 open reading frame 23 |
|
increases expression |
EXP |
12 |
107,349,544 |
107,367,813 |
RGD:6480464 |
CTD |
| G |
C14orf105 |
chromosome 14 open reading frame 105 |
|
increases expression |
EXP |
14 |
57,936,595 |
57,960,576 |
RGD:6480464 |
CTD |
| G |
C14orf142 |
chromosome 14 open reading frame 142 |
|
increases expression |
EXP |
14 |
93,669,237 |
93,673,459 |
RGD:6480464 |
CTD |
| G |
C16orf45 |
chromosome 16 open reading frame 45 |
|
multiple interactions |
EXP |
16 |
15,528,325 |
15,682,116 |
RGD:6480464 |
CTD |
| G |
C19orf26 |
chromosome 19 open reading frame 26 |
|
decreases expression |
ISO |
19 |
1,229,947 |
1,237,990 |
RGD:6480464 |
CTD |
| G |
C3orf33 |
chromosome 3 open reading frame 33 |
|
decreases expression |
EXP |
3 |
155,480,401 |
155,524,055 |
RGD:6480464 |
CTD |
| G |
C3orf35 |
chromosome 3 open reading frame 35 |
|
decreases expression |
EXP |
3 |
37,440,968 |
37,476,988 |
RGD:6480464 |
CTD |
| G |
C4BPA |
complement component 4 binding protein, alpha |
|
decreases expression |
EXP |
1 |
207,277,607 |
207,318,317 |
RGD:6480464 |
CTD |
| G |
C4orf32 |
chromosome 4 open reading frame 32 |
|
increases expression |
EXP |
4 |
113,066,553 |
113,110,237 |
RGD:6480464 |
CTD |
| G |
C5 |
complement component 5 |
|
decreases expression |
EXP |
9 |
123,714,613 |
123,812,554 |
RGD:6480464 |
CTD |
| G |
C5 |
complement component 5 |
|
increases expression |
EXP |
9 |
123,714,613 |
123,812,554 |
RGD:6480464 |
CTD |
| G |
C5AR1 |
complement component 5a receptor 1 |
|
increases expression |
EXP |
19 |
47,813,104 |
47,825,327 |
RGD:6480464 |
CTD |
| G |
C6 |
complement component 6 |
|
decreases expression |
EXP |
5 |
41,142,336 |
41,261,540 |
RGD:6480464 |
CTD |
| G |
C6 |
complement component 6 |
|
multiple interactions |
ISO |
5 |
41,142,336 |
41,261,540 |
RGD:6480464 |
CTD |
| G |
C8G |
complement component 8, gamma polypeptide |
|
affects expression |
ISO |
9 |
139,839,698 |
139,841,426 |
RGD:6480464 |
CTD |
| G |
C8G |
complement component 8, gamma polypeptide |
|
increases expression |
EXP |
9 |
139,839,698 |
139,841,426 |
RGD:6480464 |
CTD |
| G |
C8orf4 |
chromosome 8 open reading frame 4 |
|
multiple interactions |
EXP |
8 |
40,010,987 |
40,012,827 |
RGD:6480464 |
CTD |
| G |
C8orf4 |
chromosome 8 open reading frame 4 |
|
decreases expression |
EXP |
8 |
40,010,987 |
40,012,827 |
RGD:6480464 |
CTD |
| G |
C8orf58 |
chromosome 8 open reading frame 58 |
|
increases expression |
EXP |
8 |
22,457,114 |
22,461,663 |
RGD:6480464 |
CTD |
| G |
C9orf91 |
chromosome 9 open reading frame 91 |
|
decreases expression |
EXP |
9 |
117,373,706 |
117,408,703 |
RGD:6480464 |
CTD |
| G |
CA11 |
carbonic anhydrase XI |
|
multiple interactions |
EXP |
19 |
49,141,272 |
49,149,451 |
RGD:6480464 |
CTD |
| G |
CA11 |
carbonic anhydrase XI |
|
decreases expression |
EXP |
19 |
49,141,272 |
49,149,451 |
RGD:6480464 |
CTD |
| G |
CA12 |
carbonic anhydrase XII |
|
increases expression |
EXP |
15 |
63,615,730 |
63,674,075 |
RGD:6480464 |
CTD |
| G |
CA12 |
carbonic anhydrase XII |
|
multiple interactions |
EXP |
15 |
63,615,730 |
63,674,075 |
RGD:6480464 |
CTD |
| G |
CA2 |
carbonic anhydrase II |
|
multiple interactions |
EXP |
8 |
86,376,131 |
86,393,721 |
RGD:6480464 |
CTD |
| G |
CA2 |
carbonic anhydrase II |
|
decreases expression |
ISO |
8 |
86,376,131 |
86,393,721 |
RGD:6480464 |
CTD |
| G |
CA2 |
carbonic anhydrase II |
|
decreases expression |
EXP |
8 |
86,376,131 |
86,393,721 |
RGD:6480464 |
CTD |
| G |
CA3 |
carbonic anhydrase III, muscle specific |
|
affects expression |
ISO |
8 |
86,351,056 |
86,361,269 |
RGD:6480464 |
CTD |
| G |
CA3 |
carbonic anhydrase III, muscle specific |
|
multiple interactions |
ISO |
8 |
86,351,056 |
86,361,269 |
RGD:6480464 |
CTD |
| G |
CA3 |
carbonic anhydrase III, muscle specific |
|
decreases expression |
ISO |
8 |
86,351,056 |
86,361,269 |
RGD:6480464 |
CTD |
| G |
CA3 |
carbonic anhydrase III, muscle specific |
|
decreases expression |
ISO |
8 |
86,351,056 |
86,361,269 |
RGD:6480464 |
CTD |
| G |
CA3 |
carbonic anhydrase III, muscle specific |
|
decreases expression |
ISO |
8 |
86,351,056 |
86,361,269 |
RGD:6480464 |
CTD |
| G |
CA3 |
carbonic anhydrase III, muscle specific |
|
decreases expression |
ISO |
8 |
86,351,056 |
86,361,269 |
RGD:6480464 |
CTD |
| G |
CA5B |
carbonic anhydrase VB, mitochondrial |
|
multiple interactions |
ISO |
X |
15,756,412 |
15,805,748 |
RGD:6480464 |
CTD |
| G |
CA8 |
carbonic anhydrase VIII |
|
affects expression |
ISO |
8 |
61,101,423 |
61,193,954 |
RGD:6480464 |
CTD |
| G |
CA9 |
carbonic anhydrase IX |
|
multiple interactions |
EXP |
9 |
35,673,915 |
35,681,156 |
RGD:6480464 |
CTD |
| G |
CA9 |
carbonic anhydrase IX |
|
multiple interactions |
ISO |
9 |
35,673,915 |
35,681,156 |
RGD:6480464 |
CTD |
| G |
CAB39L |
calcium binding protein 39-like |
|
multiple interactions |
ISO |
13 |
49,882,786 |
50,018,221 |
RGD:6480464 |
CTD |
| G |
CABIN1 |
calcineurin binding protein 1 |
|
multiple interactions |
ISO |
22 |
24,407,765 |
24,574,596 |
RGD:6480464 |
CTD |
| G |
CABYR |
calcium binding tyrosine-(Y)-phosphorylation regulated |
|
multiple interactions |
ISO |
18 |
21,718,955 |
21,741,564 |
RGD:6480464 |
CTD |
| G |
CABYR |
calcium binding tyrosine-(Y)-phosphorylation regulated |
|
multiple interactions |
ISO |
18 |
21,718,955 |
21,741,564 |
RGD:6480464 |
CTD |
| G |
CABYR |
calcium binding tyrosine-(Y)-phosphorylation regulated |
|
decreases expression |
ISO |
18 |
21,718,955 |
21,741,564 |
RGD:6480464 |
CTD |
| G |
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
decreases expression |
ISO |
12 |
2,162,416 |
2,807,115 |
RGD:6480464 |
CTD |
| G |
CACNA1D |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
multiple interactions |
EXP |
3 |
53,529,031 |
53,846,492 |
RGD:6480464 |
CTD |
| G |
CACNA1D |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
increases expression |
EXP |
3 |
53,529,031 |
53,846,492 |
RGD:6480464 |
CTD |
| G |
CACNA1G |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
multiple interactions |
ISO |
17 |
48,638,429 |
48,704,835 |
RGD:6480464 |
CTD |
| G |
CACNA1S |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
|
multiple interactions |
ISO |
1 |
201,008,640 |
201,081,694 |
RGD:6480464 |
CTD |
| G |
CACNA1S |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
|
multiple interactions |
ISO |
1 |
201,008,640 |
201,081,694 |
RGD:6480464 |
CTD |
| G |
CACNB2 |
calcium channel, voltage-dependent, beta 2 subunit |
|
decreases expression |
EXP |
10 |
18,429,606 |
18,830,688 |
RGD:6480464 |
CTD |
| G |
CACNG4 |
calcium channel, voltage-dependent, gamma subunit 4 |
|
decreases expression |
EXP |
17 |
64,960,980 |
65,029,518 |
RGD:6480464 |
CTD |
| G |
CACNG4 |
calcium channel, voltage-dependent, gamma subunit 4 |
|
multiple interactions |
EXP |
17 |
64,960,980 |
65,029,518 |
RGD:6480464 |
CTD |
| G |
CACNG4 |
calcium channel, voltage-dependent, gamma subunit 4 |
|
multiple interactions |
ISO |
17 |
64,960,980 |
65,029,518 |
RGD:6480464 |
CTD |
| G |
CACYBP |
calcyclin binding protein |
|
multiple interactions |
ISO |
1 |
174,968,571 |
174,981,163 |
RGD:6480464 |
CTD |
| G |
CACYBP |
calcyclin binding protein |
|
decreases expression |
ISO |
1 |
174,968,571 |
174,981,163 |
RGD:6480464 |
CTD |
| G |
CACYBP |
calcyclin binding protein |
|
increases expression |
ISO |
1 |
174,968,571 |
174,981,163 |
RGD:6480464 |
CTD |
| G |
CAD |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
multiple interactions |
EXP |
2 |
27,440,258 |
27,466,654 |
RGD:6480464 |
CTD |
| G |
CADPS2 |
Ca++-dependent secretion activator 2 |
|
multiple interactions |
ISO |
7 |
121,958,478 |
122,526,813 |
RGD:6480464 |
CTD |
| G |
CADPS2 |
Ca++-dependent secretion activator 2 |
|
decreases expression |
EXP |
7 |
121,958,478 |
122,526,813 |
RGD:6480464 |
CTD |
| G |
CADPS2 |
Ca++-dependent secretion activator 2 |
|
multiple interactions |
EXP |
7 |
121,958,478 |
122,526,813 |
RGD:6480464 |
CTD |
| G |
CADPS2 |
Ca++-dependent secretion activator 2 |
|
multiple interactions |
ISO |
7 |
121,958,478 |
122,526,813 |
RGD:6480464 |
CTD |
| G |
CALB1 |
calbindin 1, 28kDa |
|
decreases expression |
EXP |
8 |
91,070,838 |
91,095,107 |
RGD:6480464 |
CTD |
| G |
CALB1 |
calbindin 1, 28kDa |
|
multiple interactions |
EXP |
8 |
91,070,838 |
91,095,107 |
RGD:6480464 |
CTD |
| G |
CALB1 |
calbindin 1, 28kDa |
|
multiple interactions |
ISO |
8 |
91,070,838 |
91,095,107 |
RGD:6480464 |
CTD |
| G |
CALB1 |
calbindin 1, 28kDa |
|
decreases expression |
ISO |
8 |
91,070,838 |
91,095,107 |
RGD:6480464 |
CTD |
| G |
CALCOCO1 |
calcium binding and coiled-coil domain 1 |
|
increases expression |
ISO |
12 |
54,104,902 |
54,121,307 |
RGD:6480464 |
CTD |
| G |
CALCR |
calcitonin receptor |
|
multiple interactions |
EXP |
7 |
93,053,799 |
93,204,042 |
RGD:6480464 |
CTD |
| G |
CALCR |
calcitonin receptor |
|
decreases expression |
EXP |
7 |
93,053,799 |
93,204,042 |
RGD:6480464 |
CTD |
| G |
CAPZA1 |
capping protein (actin filament) muscle Z-line, alpha 1 |
|
multiple interactions |
ISO |
1 |
113,162,075 |
113,214,241 |
RGD:6480464 |
CTD |
| G |
CARD10 |
caspase recruitment domain family, member 10 |
|
increases expression |
EXP |
22 |
37,886,400 |
37,915,210 |
RGD:6480464 |
CTD |
| G |
CARD10 |
caspase recruitment domain family, member 10 |
|
decreases expression |
ISO |
22 |
37,886,400 |
37,915,210 |
RGD:6480464 |
CTD |
| G |
CARD10 |
caspase recruitment domain family, member 10 |
|
multiple interactions |
ISO |
22 |
37,886,400 |
37,915,210 |
RGD:6480464 |
CTD |
| G |
CARD6 |
caspase recruitment domain family, member 6 |
|
increases expression |
ISO |
5 |
40,841,410 |
40,855,456 |
RGD:6480464 |
CTD |
| G |
CARHSP1 |
calcium regulated heat stable protein 1, 24kDa |
|
multiple interactions |
ISO |
16 |
8,946,802 |
8,962,863 |
RGD:6480464 |
CTD |
| G |
CARHSP1 |
calcium regulated heat stable protein 1, 24kDa |
|
decreases expression |
ISO |
16 |
8,946,802 |
8,962,863 |
RGD:6480464 |
CTD |
| G |
CARS |
cysteinyl-tRNA synthetase |
|
multiple interactions |
ISO |
11 |
3,022,152 |
3,078,681 |
RGD:6480464 |
CTD |
| G |
CARTPT |
CART prepropeptide |
|
multiple interactions |
ISO |
5 |
71,014,990 |
71,016,875 |
RGD:6480464 |
CTD |
| G |
CARTPT |
CART prepropeptide |
|
increases expression |
ISO |
5 |
71,014,990 |
71,016,875 |
RGD:6480464 |
CTD |
| G |
CASC3 |
cancer susceptibility candidate 3 |
|
increases expression |
ISO |
17 |
38,296,507 |
38,328,431 |
RGD:6480464 |
CTD |
| G |
CASD1 |
CAS1 domain containing 1 |
|
increases expression |
ISO |
7 |
94,139,170 |
94,186,331 |
RGD:6480464 |
CTD |
| G |
CASD1 |
CAS1 domain containing 1 |
|
decreases expression |
EXP |
7 |
94,139,170 |
94,186,331 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
decreases expression |
EXP |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP14 |
caspase 14, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
19 |
15,160,291 |
15,169,104 |
RGD:6480464 |
CTD |
| G |
CASP14 |
caspase 14, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
19 |
15,160,291 |
15,169,104 |
RGD:6480464 |
CTD |
| G |
CASP2 |
caspase 2, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
7 |
142,985,308 |
143,004,789 |
RGD:6480464 |
CTD |
| G |
CASP2 |
caspase 2, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
7 |
142,985,308 |
143,004,789 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
11 |
104,813,594 |
104,839,325 |
RGD:6480464 |
CTD |
| G |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
11 |
104,813,594 |
104,839,325 |
RGD:6480464 |
CTD |
| G |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
11 |
104,813,594 |
104,839,325 |
RGD:6480464 |
CTD |
| G |
CASP6 |
caspase 6, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
4 |
110,609,785 |
110,624,629 |
RGD:6480464 |
CTD |
| G |
CASP6 |
caspase 6, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
110,609,785 |
110,624,629 |
RGD:6480464 |
CTD |
| G |
CASP6 |
caspase 6, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
4 |
110,609,785 |
110,624,629 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
decreases expression |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8AP2 |
caspase 8 associated protein 2 |
|
decreases expression |
ISO |
6 |
90,539,619 |
90,584,155 |
RGD:6480464 |
CTD |
| G |
CASP8AP2 |
caspase 8 associated protein 2 |
|
increases expression |
ISO |
6 |
90,539,619 |
90,584,155 |
RGD:6480464 |
CTD |
| G |
CASP8AP2 |
caspase 8 associated protein 2 |
|
increases expression |
ISO |
6 |
90,539,619 |
90,584,155 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CCL1 |
chemokine (C-C motif) ligand 1 |
|
multiple interactions |
EXP |
17 |
32,687,399 |
32,690,252 |
RGD:6480464 |
CTD |
| G |
CCL1 |
chemokine (C-C motif) ligand 1 |
|
increases expression |
EXP |
17 |
32,687,399 |
32,690,252 |
RGD:6480464 |
CTD |
| G |
CCL1 |
chemokine (C-C motif) ligand 1 |
|
increases expression |
EXP |
17 |
32,687,399 |
32,690,252 |
RGD:6480464 |
CTD |
| G |
CCL1 |
chemokine (C-C motif) ligand 1 |
|
increases expression |
ISO |
17 |
32,687,399 |
32,690,252 |
RGD:6480464 |
CTD |
| G |
CCL11 |
chemokine (C-C motif) ligand 11 |
|
multiple interactions |
ISO |
17 |
32,612,687 |
32,615,199 |
RGD:6480464 |
CTD |
| G |
CCL17 |
chemokine (C-C motif) ligand 17 |
|
multiple interactions |
ISO |
16 |
57,438,679 |
57,449,974 |
RGD:6480464 |
CTD |
| G |
CCL17 |
chemokine (C-C motif) ligand 17 |
|
increases expression |
ISO |
16 |
57,438,679 |
57,449,974 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
ISO |
2 |
228,678,558 |
228,682,280 |
RGD:6480464 |
CTD |
| G |
CCL20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
EXP |
2 |
228,678,558 |
228,682,280 |
RGD:6480464 |
CTD |
| G |
CCL21 |
chemokine (C-C motif) ligand 21 |
|
multiple interactions |
ISO |
9 |
34,709,002 |
34,710,147 |
RGD:6480464 |
CTD |
| G |
CCL21 |
chemokine (C-C motif) ligand 21 |
|
decreases expression |
ISO |
9 |
34,709,002 |
34,710,147 |
RGD:6480464 |
CTD |
| G |
CCL5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
EXP |
17 |
34,198,495 |
34,207,377 |
RGD:6480464 |
CTD |
| G |
CCL5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
EXP |
17 |
34,198,495 |
34,207,377 |
RGD:6480464 |
CTD |
| G |
CCL5 |
chemokine (C-C motif) ligand 5 |
|
increases expression |
EXP |
17 |
34,198,495 |
34,207,377 |
RGD:6480464 |
CTD |
| G |
CCL5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
17 |
34,198,495 |
34,207,377 |
RGD:6480464 |
CTD |
| G |
CCL5 |
chemokine (C-C motif) ligand 5 |
|
decreases expression |
ISO |
17 |
34,198,495 |
34,207,377 |
RGD:6480464 |
CTD |
| G |
CCL5 |
chemokine (C-C motif) ligand 5 |
|
decreases expression |
ISO |
17 |
34,198,495 |
34,207,377 |
RGD:6480464 |
CTD |
| G |
CCL7 |
chemokine (C-C motif) ligand 7 |
|
multiple interactions |
ISO |
17 |
32,597,240 |
32,599,256 |
RGD:6480464 |
CTD |
| G |
CCL7 |
chemokine (C-C motif) ligand 7 |
|
decreases expression |
ISO |
17 |
32,597,240 |
32,599,256 |
RGD:6480464 |
CTD |
| G |
CCL8 |
chemokine (C-C motif) ligand 8 |
|
multiple interactions |
ISO |
17 |
32,646,066 |
32,648,421 |
RGD:6480464 |
CTD |
| G |
CCNA2 |
cyclin A2 |
|
multiple interactions |
ISO |
4 |
122,737,599 |
122,745,088 |
RGD:6480464 |
CTD |
| G |
CCNA2 |
cyclin A2 |
|
decreases expression |
ISO |
4 |
122,737,599 |
122,745,088 |
RGD:6480464 |
CTD |
| G |
CCNA2 |
cyclin A2 |
|
increases expression |
ISO |
4 |
122,737,599 |
122,745,088 |
RGD:6480464 |
CTD |
| G |
CCNA2 |
cyclin A2 |
|
multiple interactions |
ISO |
4 |
122,737,599 |
122,745,088 |
RGD:6480464 |
CTD |
| G |
CCNA2 |
cyclin A2 |
|
increases expression |
ISO |
4 |
122,737,599 |
122,745,088 |
RGD:6480464 |
CTD |
| G |
CCNB1 |
cyclin B1 |
|
multiple interactions |
ISO |
5 |
68,462,837 |
68,474,072 |
RGD:6480464 |
CTD |
| G |
CCNB1 |
cyclin B1 |
|
decreases expression |
ISO |
5 |
68,462,837 |
68,474,072 |
RGD:6480464 |
CTD |
| G |
CCNB1 |
cyclin B1 |
|
increases expression |
ISO |
5 |
68,462,837 |
68,474,072 |
RGD:6480464 |
CTD |
| G |
CCNB2 |
cyclin B2 |
|
increases expression |
EXP |
15 |
59,397,284 |
59,417,244 |
RGD:6480464 |
CTD |
| G |
CCNB2 |
cyclin B2 |
|
decreases expression |
ISO |
15 |
59,397,284 |
59,417,244 |
RGD:6480464 |
CTD |
| G |
CCNB2 |
cyclin B2 |
|
multiple interactions |
ISO |
15 |
59,397,284 |
59,417,244 |
RGD:6480464 |
CTD |
| G |
CCNC |
cyclin C |
|
decreases expression |
EXP |
6 |
99,990,263 |
100,016,690 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
affects expression |
EXP |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
decreases expression |
EXP |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
decreases expression |
EXP |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
multiple interactions |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
multiple interactions |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
multiple interactions |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
increases expression |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
multiple interactions |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
decreases expression |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
decreases expression |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND2 |
cyclin D2 |
|
multiple interactions |
ISO |
12 |
4,382,902 |
4,414,522 |
RGD:6480464 |
CTD |
| G |
CCND2 |
cyclin D2 |
|
decreases expression |
ISO |
12 |
4,382,902 |
4,414,522 |
RGD:6480464 |
CTD |
| G |
CCND2 |
cyclin D2 |
|
multiple interactions |
ISO |
12 |
4,382,902 |
4,414,522 |
RGD:6480464 |
CTD |
| G |
CCND3 |
cyclin D3 |
|
multiple interactions |
ISO |
6 |
41,902,671 |
42,016,610 |
RGD:6480464 |
CTD |
| G |
CCND3 |
cyclin D3 |
|
affects expression |
ISO |
6 |
41,902,671 |
42,016,610 |
RGD:6480464 |
CTD |
| G |
CCND3 |
cyclin D3 |
|
increases expression |
ISO |
6 |
41,902,671 |
42,016,610 |
RGD:6480464 |
CTD |
| G |
CCNE1 |
cyclin E1 |
|
multiple interactions |
ISO |
19 |
30,302,901 |
30,315,215 |
RGD:6480464 |
CTD |
| G |
CCNE1 |
cyclin E1 |
|
decreases expression |
ISO |
19 |
30,302,901 |
30,315,215 |
RGD:6480464 |
CTD |
| G |
CCNE2 |
cyclin E2 |
|
decreases expression |
ISO |
8 |
95,892,452 |
95,907,482 |
RGD:6480464 |
CTD |
| G |
CCNF |
cyclin F |
|
multiple interactions |
ISO |
16 |
2,479,395 |
2,508,859 |
RGD:6480464 |
CTD |
| G |
CCNF |
cyclin F |
|
increases expression |
ISO |
16 |
2,479,395 |
2,508,859 |
RGD:6480464 |
CTD |
| G |
CD14 |
CD14 molecule |
|
decreases expression |
ISO |
5 |
140,011,313 |
140,013,286 |
RGD:6480464 |
CTD |
| G |
CD160 |
CD160 molecule |
|
increases expression |
ISO |
1 |
145,695,798 |
145,715,565 |
RGD:6480464 |
CTD |
| G |
CD164 |
CD164 molecule, sialomucin |
|
multiple interactions |
ISO |
6 |
109,687,717 |
109,703,762 |
RGD:6480464 |
CTD |
| G |
CD200 |
CD200 molecule |
|
multiple interactions |
ISO |
3 |
112,051,916 |
112,081,659 |
RGD:6480464 |
CTD |
| G |
CD22 |
CD22 molecule |
|
multiple interactions |
ISO |
19 |
35,820,072 |
35,838,264 |
RGD:6480464 |
CTD |
| G |
CD24 |
CD24 molecule |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
CD24 |
CD24 molecule |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
CD24 |
CD24 molecule |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
CD24 |
CD24 molecule |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
CD24 |
CD24 molecule |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
CD248 |
CD248 molecule, endosialin |
|
increases expression |
ISO |
11 |
66,081,958 |
66,084,515 |
RGD:6480464 |
CTD |
| G |
CD276 |
CD276 molecule |
|
increases expression |
ISO |
15 |
73,976,622 |
74,006,859 |
RGD:6480464 |
CTD |
| G |
CD28 |
CD28 molecule |
|
decreases expression |
ISO |
2 |
204,571,198 |
204,603,635 |
RGD:6480464 |
CTD |
| G |
CD28 |
CD28 molecule |
|
increases expression |
ISO |
2 |
204,571,198 |
204,603,635 |
RGD:6480464 |
CTD |
| G |
CD2BP2 |
CD2 (cytoplasmic tail) binding protein 2 |
|
multiple interactions |
ISO |
16 |
30,362,087 |
30,366,682 |
RGD:6480464 |
CTD |
| G |
CD302 |
CD302 molecule |
|
affects expression |
ISO |
2 |
160,625,139 |
160,654,766 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
EXP |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
EXP |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
EXP |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
affects expression |
ISO |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
ISO |
7 |
80,231,504 |
80,308,593 |
RGD:6480464 |
CTD |
| G |
CD38 |
CD38 molecule |
|
increases expression |
ISO |
4 |
15,779,931 |
15,850,706 |
RGD:6480464 |
CTD |
| G |
CD38 |
CD38 molecule |
|
multiple interactions |
ISO |
4 |
15,779,931 |
15,850,706 |
RGD:6480464 |
CTD |
| G |
CD3D |
CD3d molecule, delta (CD3-TCR complex) |
|
affects expression |
ISO |
11 |
118,209,789 |
118,213,459 |
RGD:6480464 |
CTD |
| G |
CD3D |
CD3d molecule, delta (CD3-TCR complex) |
|
multiple interactions |
ISO |
11 |
118,209,789 |
118,213,459 |
RGD:6480464 |
CTD |
| G |
CD3D |
CD3d molecule, delta (CD3-TCR complex) |
|
decreases expression |
ISO |
11 |
118,209,789 |
118,213,459 |
RGD:6480464 |
CTD |
| G |
CD3E |
CD3e molecule, epsilon (CD3-TCR complex) |
|
multiple interactions |
EXP |
11 |
118,175,295 |
118,186,890 |
RGD:6480464 |
CTD |
| G |
CD3E |
CD3e molecule, epsilon (CD3-TCR complex) |
|
decreases expression |
EXP |
11 |
118,175,295 |
118,186,890 |
RGD:6480464 |
CTD |
| G |
CD3E |
CD3e molecule, epsilon (CD3-TCR complex) |
|
multiple interactions |
ISO |
11 |
118,175,295 |
118,186,890 |
RGD:6480464 |
CTD |
| G |
CD3E |
CD3e molecule, epsilon (CD3-TCR complex) |
|
increases expression |
ISO |
11 |
118,175,295 |
118,186,890 |
RGD:6480464 |
CTD |
| G |
CD4 |
CD4 molecule |
|
multiple interactions |
ISO |
12 |
6,898,638 |
6,929,976 |
RGD:6480464 |
CTD |
| G |
CD4 |
CD4 molecule |
|
multiple interactions |
ISO |
12 |
6,898,638 |
6,929,976 |
RGD:6480464 |
CTD |
| G |
CD4 |
CD4 molecule |
|
decreases expression |
ISO |
12 |
6,898,638 |
6,929,976 |
RGD:6480464 |
CTD |
| G |
CD40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
increases expression |
ISO |
20 |
44,746,906 |
44,758,384 |
RGD:6480464 |
CTD |
| G |
CD40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
increases expression |
ISO |
20 |
44,746,906 |
44,758,384 |
RGD:6480464 |
CTD |
| G |
CD40LG |
CD40 ligand |
|
decreases response to substance |
EXP |
X |
135,730,336 |
135,742,549 |
RGD:6480464 |
CTD |
| G |
CD40LG |
CD40 ligand |
|
increases expression |
ISO |
X |
135,730,336 |
135,742,549 |
RGD:6480464 |
CTD |
| G |
CD40LG |
CD40 ligand |
|
decreases response to substance |
ISO |
X |
135,730,336 |
135,742,549 |
RGD:6480464 |
CTD |
| G |
CD44 |
CD44 molecule (Indian blood group) |
|
increases expression |
EXP |
11 |
35,160,417 |
35,253,949 |
RGD:6480464 |
CTD |
| G |
CD44 |
CD44 molecule (Indian blood group) |
|
multiple interactions |
EXP |
11 |
35,160,417 |
35,253,949 |
RGD:6480464 |
CTD |
| G |
CD44 |
CD44 molecule (Indian blood group) |
|
multiple interactions |
ISO |
11 |
35,160,417 |
35,253,949 |
RGD:6480464 |
CTD |
| G |
CD44 |
CD44 molecule (Indian blood group) |
|
multiple interactions |
ISO |
11 |
35,160,417 |
35,253,949 |
RGD:6480464 |
CTD |
| G |
CD44 |
CD44 molecule (Indian blood group) |
|
increases expression |
ISO |
11 |
35,160,417 |
35,253,949 |
RGD:6480464 |
CTD |
| G |
CD44 |
CD44 molecule (Indian blood group) |
|
increases expression |
ISO |
11 |
35,160,417 |
35,253,949 |
RGD:6480464 |
CTD |
| G |
CD47 |
CD47 molecule |
|
multiple interactions |
EXP |
3 |
107,761,941 |
107,809,935 |
RGD:6480464 |
CTD |
| G |
CD47 |
CD47 molecule |
|
increases expression |
EXP |
3 |
107,761,941 |
107,809,935 |
RGD:6480464 |
CTD |
| G |
CD47 |
CD47 molecule |
|
decreases expression |
EXP |
3 |
107,761,941 |
107,809,935 |
RGD:6480464 |
CTD |
| G |
CD47 |
CD47 molecule |
|
decreases expression |
ISO |
3 |
107,761,941 |
107,809,935 |
RGD:6480464 |
CTD |
| G |
CD47 |
CD47 molecule |
|
increases expression |
ISO |
3 |
107,761,941 |
107,809,935 |
RGD:6480464 |
CTD |
| G |
CD48 |
CD48 molecule |
|
multiple interactions |
ISO |
1 |
160,648,536 |
160,681,641 |
RGD:6480464 |
CTD |
| G |
CD5 |
CD5 molecule |
|
decreases expression |
ISO |
11 |
60,869,930 |
60,895,324 |
RGD:6480464 |
CTD |
| G |
CD52 |
CD52 molecule |
|
increases expression |
ISO |
1 |
26,644,411 |
26,647,014 |
RGD:6480464 |
CTD |
| G |
CD53 |
CD53 molecule |
|
multiple interactions |
ISO |
1 |
111,413,821 |
111,442,558 |
RGD:6480464 |
CTD |
| G |
CD53 |
CD53 molecule |
|
increases expression |
ISO |
1 |
111,413,821 |
111,442,558 |
RGD:6480464 |
CTD |
| G |
CD55 |
CD55 molecule, decay accelerating factor for complement (Cromer blood group) |
|
multiple interactions |
ISO |
1 |
207,494,817 |
207,534,311 |
RGD:6480464 |
CTD |
| G |
CD55 |
CD55 molecule, decay accelerating factor for complement (Cromer blood group) |
|
decreases expression |
ISO |
1 |
207,494,817 |
207,534,311 |
RGD:6480464 |
CTD |
| G |
CD5L |
CD5 molecule-like |
|
decreases expression |
ISO |
1 |
157,800,704 |
157,811,634 |
RGD:6480464 |
CTD |
| G |
CD63 |
CD63 molecule |
|
multiple interactions |
EXP |
12 |
56,119,227 |
56,123,457 |
RGD:6480464 |
CTD |
| G |
CD63 |
CD63 molecule |
|
increases expression |
EXP |
12 |
56,119,227 |
56,123,457 |
RGD:6480464 |
CTD |
| G |
CD63 |
CD63 molecule |
|
multiple interactions |
ISO |
12 |
56,119,227 |
56,123,457 |
RGD:6480464 |
CTD |
| G |
CD69 |
CD69 molecule |
|
multiple interactions |
ISO |
12 |
9,905,082 |
9,913,497 |
RGD:6480464 |
CTD |
| G |
CD7 |
CD7 molecule |
|
multiple interactions |
ISO |
17 |
80,272,746 |
80,275,480 |
RGD:6480464 |
CTD |
| G |
CD7 |
CD7 molecule |
|
increases expression |
EXP |
17 |
80,272,746 |
80,275,480 |
RGD:6480464 |
CTD |
| G |
CD70 |
CD70 molecule |
|
increases expression |
ISO |
19 |
6,585,850 |
6,591,163 |
RGD:6480464 |
CTD |
| G |
CD74 |
CD74 molecule, major histocompatibility complex, class II invariant chain |
|
multiple interactions |
ISO |
5 |
149,781,200 |
149,792,499 |
RGD:6480464 |
CTD |
| G |
CD79B |
CD79b molecule, immunoglobulin-associated beta |
|
multiple interactions |
ISO |
17 |
62,006,098 |
62,009,704 |
RGD:6480464 |
CTD |
| G |
CDC6 |
cell division cycle 6 |
|
increases expression |
ISO |
17 |
38,444,146 |
38,459,413 |
RGD:6480464 |
CTD |
| G |
CDC6 |
cell division cycle 6 |
|
multiple interactions |
ISO |
17 |
38,444,146 |
38,459,413 |
RGD:6480464 |
CTD |
| G |
CDC6 |
cell division cycle 6 |
|
decreases expression |
ISO |
17 |
38,444,146 |
38,459,413 |
RGD:6480464 |
CTD |
| G |
CDC7 |
cell division cycle 7 |
|
decreases expression |
EXP |
1 |
91,966,404 |
91,991,321 |
RGD:6480464 |
CTD |
| G |
CDC7 |
cell division cycle 7 |
|
multiple interactions |
ISO |
1 |
91,966,404 |
91,991,321 |
RGD:6480464 |
CTD |
| G |
CDCA2 |
cell division cycle associated 2 |
|
increases expression |
ISO |
8 |
25,316,513 |
25,365,425 |
RGD:6480464 |
CTD |
| G |
CDCA4 |
cell division cycle associated 4 |
|
multiple interactions |
ISO |
14 |
105,475,910 |
105,487,425 |
RGD:6480464 |
CTD |
| G |
CDCA5 |
cell division cycle associated 5 |
|
increases expression |
EXP |
11 |
64,844,927 |
64,851,615 |
RGD:6480464 |
CTD |
| G |
CDCA5 |
cell division cycle associated 5 |
|
multiple interactions |
ISO |
11 |
64,844,927 |
64,851,615 |
RGD:6480464 |
CTD |
| G |
CDCA5 |
cell division cycle associated 5 |
|
multiple interactions |
EXP |
11 |
64,844,927 |
64,851,615 |
RGD:6480464 |
CTD |
| G |
CDCA5 |
cell division cycle associated 5 |
|
increases expression |
ISO |
11 |
64,844,927 |
64,851,615 |
RGD:6480464 |
CTD |
| G |
CDCA7 |
cell division cycle associated 7 |
|
decreases expression |
EXP |
2 |
174,219,561 |
174,233,718 |
RGD:6480464 |
CTD |
| G |
CDCA8 |
cell division cycle associated 8 |
|
multiple interactions |
ISO |
1 |
38,158,073 |
38,175,391 |
RGD:6480464 |
CTD |
| G |
CDH1 |
cadherin 1, type 1, E-cadherin (epithelial) |
|
decreases expression |
EXP |
16 |
68,771,195 |
68,869,444 |
RGD:6480464 |
CTD |
| G |
CDH1 |
cadherin 1, type 1, E-cadherin (epithelial) |
|
decreases expression |
EXP |
16 |
68,771,195 |
68,869,444 |
RGD:6480464 |
CTD |
| G |
CDH1 |
cadherin 1, type 1, E-cadherin (epithelial) |
|
increases expression |
EXP |
16 |
68,771,195 |
68,869,444 |
RGD:6480464 |
CTD |
| G |
CDH1 |
cadherin 1, type 1, E-cadherin (epithelial) |
|
decreases expression |
ISO |
16 |
68,771,195 |
68,869,444 |
RGD:6480464 |
CTD |
| G |
CDH1 |
cadherin 1, type 1, E-cadherin (epithelial) |
|
multiple interactions |
ISO |
16 |
68,771,195 |
68,869,444 |
RGD:6480464 |
CTD |
| G |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
|
multiple interactions |
EXP |
16 |
64,980,683 |
65,155,919 |
RGD:6480464 |
CTD |
| G |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
|
decreases expression |
EXP |
16 |
64,980,683 |
65,155,919 |
RGD:6480464 |
CTD |
| G |
CDH12 |
cadherin 12, type 2 (N-cadherin 2) |
|
increases expression |
EXP |
5 |
21,750,973 |
22,853,731 |
RGD:6480464 |
CTD |
| G |
CDH13 |
cadherin 13, H-cadherin (heart) |
|
multiple interactions |
ISO |
16 |
82,660,399 |
83,830,215 |
RGD:6480464 |
CTD |
| G |
CDH13 |
cadherin 13, H-cadherin (heart) |
|
multiple interactions |
ISO |
16 |
82,660,399 |
83,830,215 |
RGD:6480464 |
CTD |
| G |
CDH13 |
cadherin 13, H-cadherin (heart) |
|
decreases expression |
ISO |
16 |
82,660,399 |
83,830,215 |
RGD:6480464 |
CTD |
| G |
CDH13 |
cadherin 13, H-cadherin (heart) |
|
multiple interactions |
ISO |
16 |
82,660,399 |
83,830,215 |
RGD:6480464 |
CTD |
| G |
CDH13 |
cadherin 13, H-cadherin (heart) |
|
decreases expression |
ISO |
16 |
82,660,399 |
83,830,215 |
RGD:6480464 |
CTD |
| G |
CDH16 |
cadherin 16, KSP-cadherin |
|
multiple interactions |
ISO |
16 |
66,942,025 |
66,952,887 |
RGD:6480464 |
CTD |
| G |
CDH17 |
cadherin 17, LI cadherin (liver-intestine) |
|
increases expression |
EXP |
8 |
95,139,394 |
95,229,531 |
RGD:6480464 |
CTD |
| G |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
|
multiple interactions |
ISO |
18 |
25,530,930 |
25,757,445 |
RGD:6480464 |
CTD |
| G |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
|
multiple interactions |
ISO |
18 |
25,530,930 |
25,757,445 |
RGD:6480464 |
CTD |
| G |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
|
decreases expression |
ISO |
18 |
25,530,930 |
25,757,445 |
RGD:6480464 |
CTD |
| G |
CDH23 |
cadherin-related 23 |
|
multiple interactions |
ISO |
10 |
73,156,691 |
73,575,704 |
RGD:6480464 |
CTD |
| G |
CDH26 |
cadherin 26 |
|
increases expression |
ISO |
20 |
58,533,471 |
58,588,168 |
RGD:6480464 |
CTD |
| G |
CDH4 |
cadherin 4, type 1, R-cadherin (retinal) |
|
increases methylation |
ISO |
20 |
59,827,482 |
60,515,673 |
RGD:6480464 |
CTD |
| G |
CDHR1 |
cadherin-related family member 1 |
|
multiple interactions |
ISO |
10 |
85,954,412 |
85,979,377 |
RGD:6480464 |
CTD |
| G |
CDIPT |
CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
|
multiple interactions |
ISO |
16 |
29,869,678 |
29,874,578 |
RGD:6480464 |
CTD |
| G |
CDIPT |
CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
|
increases expression |
ISO |
16 |
29,869,678 |
29,874,578 |
RGD:6480464 |
CTD |
| G |
CDK1 |
cyclin-dependent kinase 1 |
|
decreases expression |
EXP |
10 |
62,538,089 |
62,554,610 |
RGD:6480464 |
CTD |
| G |
CDK1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
ISO |
10 |
62,538,089 |
62,554,610 |
RGD:6480464 |
CTD |
| G |
CDK1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
10 |
62,538,089 |
62,554,610 |
RGD:6480464 |
CTD |
| G |
CDK12 |
cyclin-dependent kinase 12 |
|
multiple interactions |
ISO |
17 |
37,617,739 |
37,690,800 |
RGD:6480464 |
CTD |
| G |
CDK14 |
cyclin-dependent kinase 14 |
|
multiple interactions |
ISO |
7 |
90,338,712 |
90,839,904 |
RGD:6480464 |
CTD |
| G |
CDK17 |
cyclin-dependent kinase 17 |
|
decreases expression |
EXP |
12 |
96,672,039 |
96,794,366 |
RGD:6480464 |
CTD |
| G |
CDK18 |
cyclin-dependent kinase 18 |
|
multiple interactions |
ISO |
1 |
205,473,684 |
205,501,921 |
RGD:6480464 |
CTD |
| G |
CDK18 |
cyclin-dependent kinase 18 |
|
increases expression |
ISO |
1 |
205,473,684 |
205,501,921 |
RGD:6480464 |
CTD |
| G |
CDK19 |
cyclin-dependent kinase 19 |
|
multiple interactions |
ISO |
6 |
110,931,181 |
111,136,412 |
RGD:6480464 |
CTD |
| G |
CDK19 |
cyclin-dependent kinase 19 |
|
increases expression |
ISO |
6 |
110,931,181 |
111,136,412 |
RGD:6480464 |
CTD |
| G |
CDK2 |
cyclin-dependent kinase 2 |
|
multiple interactions |
ISO |
12 |
56,360,556 |
56,366,568 |
RGD:6480464 |
CTD |
| G |
CDK2 |
cyclin-dependent kinase 2 |
|
decreases activity |
ISO |
12 |
56,360,556 |
56,366,568 |
RGD:6480464 |
CTD |
| G |
CDK20 |
cyclin-dependent kinase 20 |
|
multiple interactions |
ISO |
9 |
90,581,356 |
90,589,695 |
RGD:6480464 |
CTD |
| G |
CDK2AP2 |
cyclin-dependent kinase 2 associated protein 2 |
|
increases expression |
EXP |
11 |
67,273,968 |
67,276,102 |
RGD:6480464 |
CTD |
| G |
CDK3 |
cyclin-dependent kinase 3 |
|
multiple interactions |
ISO |
17 |
73,996,987 |
74,002,080 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
increases expression |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
increases expression |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK5RAP2 |
CDK5 regulatory subunit associated protein 2 |
|
increases expression |
EXP |
9 |
123,151,147 |
123,342,437 |
RGD:6480464 |
CTD |
| G |
CDK6 |
cyclin-dependent kinase 6 |
|
increases expression |
EXP |
7 |
92,234,235 |
92,465,941 |
RGD:6480464 |
CTD |
| G |
CDK6 |
cyclin-dependent kinase 6 |
|
decreases expression |
ISO |
7 |
92,234,235 |
92,465,941 |
RGD:6480464 |
CTD |
| G |
CDK6 |
cyclin-dependent kinase 6 |
|
affects expression |
ISO |
7 |
92,234,235 |
92,465,941 |
RGD:6480464 |
CTD |
| G |
CDK7 |
cyclin-dependent kinase 7 |
|
increases expression |
ISO |
5 |
68,530,622 |
68,573,257 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
decreases expression |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
decreases expression |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
affects binding |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CEBPA |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
19 |
33,790,840 |
33,793,430 |
RGD:6480464 |
CTD |
| G |
CEBPA |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
19 |
33,790,840 |
33,793,430 |
RGD:6480464 |
CTD |
| G |
CEBPA |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
increases expression |
ISO |
19 |
33,790,840 |
33,793,430 |
RGD:6480464 |
CTD |
| G |
CEBPA |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
ISO |
19 |
33,790,840 |
33,793,430 |
RGD:6480464 |
CTD |
| G |
CEBPA |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
19 |
33,790,840 |
33,793,430 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases activity |
EXP |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases response to substance |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
EXP |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
affects expression |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
decreases expression |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases activity |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
decreases expression |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
|
decreases expression |
EXP |
8 |
48,649,476 |
48,650,726 |
RGD:6480464 |
CTD |
| G |
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
EXP |
8 |
48,649,476 |
48,650,726 |
RGD:6480464 |
CTD |
| G |
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
ISO |
8 |
48,649,476 |
48,650,726 |
RGD:6480464 |
CTD |
| G |
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases activity |
ISO |
8 |
48,649,476 |
48,650,726 |
RGD:6480464 |
CTD |
| G |
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
ISO |
8 |
48,649,476 |
48,650,726 |
RGD:6480464 |
CTD |
| G |
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
ISO |
8 |
48,649,476 |
48,650,726 |
RGD:6480464 |
CTD |
| G |
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
ISO |
8 |
48,649,476 |
48,650,726 |
RGD:6480464 |
CTD |
| G |
CEBPG |
CCAAT/enhancer binding protein (C/EBP), gamma |
|
decreases expression |
EXP |
19 |
33,864,575 |
33,873,592 |
RGD:6480464 |
CTD |
| G |
CEBPZ |
CCAAT/enhancer binding protein (C/EBP), zeta |
|
multiple interactions |
ISO |
2 |
37,428,772 |
37,458,740 |
RGD:6480464 |
CTD |
| G |
CEBPZ |
CCAAT/enhancer binding protein (C/EBP), zeta |
|
increases expression |
ISO |
2 |
37,428,772 |
37,458,740 |
RGD:6480464 |
CTD |
| G |
CEBPZ |
CCAAT/enhancer binding protein (C/EBP), zeta |
|
decreases expression |
EXP |
2 |
37,428,772 |
37,458,740 |
RGD:6480464 |
CTD |
| G |
CELA1 |
chymotrypsin-like elastase family, member 1 |
|
decreases expression |
ISO |
12 |
51,722,227 |
51,740,463 |
RGD:6480464 |
CTD |
| G |
CELF2 |
CUGBP, Elav-like family member 2 |
|
multiple interactions |
ISO |
10 |
11,047,259 |
11,378,674 |
RGD:6480464 |
CTD |
| G |
CELF2 |
CUGBP, Elav-like family member 2 |
|
multiple interactions |
ISO |
10 |
11,047,259 |
11,378,674 |
RGD:6480464 |
CTD |
| G |
CELF2 |
CUGBP, Elav-like family member 2 |
|
decreases expression |
ISO |
10 |
11,047,259 |
11,378,674 |
RGD:6480464 |
CTD |
| G |
CELF5 |
CUGBP, Elav-like family member 5 |
|
increases expression |
ISO |
19 |
3,224,701 |
3,297,074 |
RGD:6480464 |
CTD |
| G |
CELSR1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
|
multiple interactions |
ISO |
22 |
46,756,731 |
46,933,067 |
RGD:6480464 |
CTD |
| G |
CELSR2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
|
multiple interactions |
ISO |
1 |
109,792,641 |
109,818,378 |
RGD:6480464 |
CTD |
| G |
CELSR2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
|
decreases expression |
EXP |
1 |
109,792,641 |
109,818,378 |
RGD:6480464 |
CTD |
| G |
CELSR2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
|
multiple interactions |
EXP |
1 |
109,792,641 |
109,818,378 |
RGD:6480464 |
CTD |
| G |
CELSR3 |
cadherin, EGF LAG seven-pass G-type receptor 3 |
|
multiple interactions |
ISO |
3 |
48,673,896 |
48,700,348 |
RGD:6480464 |
CTD |
| G |
CELSR3 |
cadherin, EGF LAG seven-pass G-type receptor 3 |
|
increases expression |
ISO |
3 |
48,673,896 |
48,700,348 |
RGD:6480464 |
CTD |
| G |
CENPA |
centromere protein A |
|
multiple interactions |
ISO |
2 |
27,008,882 |
27,017,457 |
RGD:6480464 |
CTD |
| G |
CENPL |
centromere protein L |
|
increases expression |
ISO |
1 |
173,768,688 |
173,793,777 |
RGD:6480464 |
CTD |
| G |
CENPN |
centromere protein N |
|
increases expression |
ISO |
16 |
81,040,103 |
81,066,712 |
RGD:6480464 |
CTD |
| G |
CENPQ |
centromere protein Q |
|
increases expression |
ISO |
6 |
49,431,096 |
49,460,820 |
RGD:6480464 |
CTD |
| G |
CEP19 |
centrosomal protein 19kDa |
|
increases expression |
EXP |
3 |
196,433,148 |
196,439,123 |
RGD:6480464 |
CTD |
| G |
CEP290 |
centrosomal protein 290kDa |
|
increases expression |
ISO |
12 |
88,442,790 |
88,535,993 |
RGD:6480464 |
CTD |
| G |
CEP63 |
centrosomal protein 63kDa |
|
increases expression |
ISO |
3 |
134,204,575 |
134,293,855 |
RGD:6480464 |
CTD |
| G |
CEP68 |
centrosomal protein 68kDa |
|
multiple interactions |
ISO |
2 |
65,283,495 |
65,314,142 |
RGD:6480464 |
CTD |
| G |
CEP72 |
centrosomal protein 72kDa |
|
increases expression |
ISO |
5 |
612,405 |
653,668 |
RGD:6480464 |
CTD |
| G |
CHEK1 |
checkpoint kinase 1 |
|
multiple interactions |
ISO |
11 |
125,495,031 |
125,546,150 |
RGD:6480464 |
CTD |
| G |
CHEK1 |
checkpoint kinase 1 |
|
increases expression |
ISO |
11 |
125,495,031 |
125,546,150 |
RGD:6480464 |
CTD |
| G |
CHGA |
chromogranin A (parathyroid secretory protein 1) |
|
increases expression |
ISO |
14 |
93,389,445 |
93,401,638 |
RGD:6480464 |
CTD |
| G |
CHGB |
chromogranin B (secretogranin 1) |
|
multiple interactions |
ISO |
20 |
5,891,974 |
5,906,007 |
RGD:6480464 |
CTD |
| G |
CHI3L1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
|
increases expression |
ISO |
1 |
203,148,059 |
203,155,922 |
RGD:6480464 |
CTD |
| G |
CHI3L1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
|
increases expression |
EXP |
1 |
203,148,059 |
203,155,922 |
RGD:6480464 |
CTD |
| G |
CHKA |
choline kinase alpha |
|
increases expression |
ISO |
11 |
67,820,326 |
67,888,858 |
RGD:6480464 |
CTD |
| G |
CHML |
choroideremia-like (Rab escort protein 2) |
|
decreases expression |
ISO |
1 |
241,792,166 |
241,799,232 |
RGD:6480464 |
CTD |
| G |
CHMP3 |
charged multivesicular body protein 3 |
|
multiple interactions |
ISO |
2 |
86,730,553 |
86,790,620 |
RGD:6480464 |
CTD |
| G |
CHMP7 |
charged multivesicular body protein 7 |
|
decreases expression |
ISO |
8 |
23,101,150 |
23,119,512 |
RGD:6480464 |
CTD |
| G |
CHN1 |
chimerin 1 |
|
multiple interactions |
ISO |
2 |
175,664,042 |
175,870,107 |
RGD:6480464 |
CTD |
| G |
CHN2 |
chimerin 2 |
|
decreases expression |
EXP |
7 |
29,234,121 |
29,553,944 |
RGD:6480464 |
CTD |
| G |
CHPF2 |
chondroitin polymerizing factor 2 |
|
increases expression |
ISO |
7 |
150,929,585 |
150,935,905 |
RGD:6480464 |
CTD |
| G |
CHRNA3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
|
increases expression |
ISO |
15 |
78,885,394 |
78,913,637 |
RGD:6480464 |
CTD |
| G |
CHRNE |
cholinergic receptor, nicotinic, epsilon (muscle) |
|
multiple interactions |
ISO |
17 |
4,801,064 |
4,806,369 |
RGD:6480464 |
CTD |
| G |
CHST1 |
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
|
multiple interactions |
ISO |
11 |
45,669,239 |
45,687,206 |
RGD:6480464 |
CTD |
| G |
CHST1 |
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
|
decreases expression |
ISO |
11 |
45,669,239 |
45,687,206 |
RGD:6480464 |
CTD |
| G |
CHST10 |
carbohydrate sulfotransferase 10 |
|
multiple interactions |
ISO |
2 |
101,008,322 |
101,034,130 |
RGD:6480464 |
CTD |
| G |
CHST11 |
carbohydrate (chondroitin 4) sulfotransferase 11 |
|
decreases expression |
ISO |
12 |
104,850,692 |
105,155,792 |
RGD:6480464 |
CTD |
| G |
CHST11 |
carbohydrate (chondroitin 4) sulfotransferase 11 |
|
increases expression |
ISO |
12 |
104,850,692 |
105,155,792 |
RGD:6480464 |
CTD |
| G |
CHST2 |
carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 |
|
multiple interactions |
ISO |
3 |
142,838,618 |
142,842,856 |
RGD:6480464 |
CTD |
| G |
CHST2 |
carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 |
|
increases expression |
ISO |
3 |
142,838,618 |
142,842,856 |
RGD:6480464 |
CTD |
| G |
CHST6 |
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 |
|
increases expression |
EXP |
16 |
75,507,022 |
75,528,926 |
RGD:6480464 |
CTD |
| G |
CHST9 |
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 |
|
increases expression |
EXP |
18 |
24,495,595 |
24,765,302 |
RGD:6480464 |
CTD |
| G |
CHSY1 |
chondroitin sulfate synthase 1 |
|
affects expression |
ISO |
15 |
101,715,928 |
101,792,137 |
RGD:6480464 |
CTD |
| G |
CHTF18 |
CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) |
|
increases expression |
ISO |
16 |
838,622 |
848,074 |
RGD:6480464 |
CTD |
| G |
CHTF18 |
CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
16 |
838,622 |
848,074 |
RGD:6480464 |
CTD |
| G |
CHUK |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
ISO |
10 |
101,948,124 |
101,989,344 |
RGD:6480464 |
CTD |
| G |
CIAO1 |
cytosolic iron-sulfur protein assembly 1 |
|
multiple interactions |
ISO |
2 |
96,931,884 |
96,939,917 |
RGD:6480464 |
CTD |
| G |
CIB1 |
calcium and integrin binding 1 (calmyrin) |
|
increases expression |
EXP |
15 |
90,773,477 |
90,777,279 |
RGD:6480464 |
CTD |
| G |
CIB1 |
calcium and integrin binding 1 (calmyrin) |
|
multiple interactions |
ISO |
15 |
90,773,477 |
90,777,279 |
RGD:6480464 |
CTD |
| G |
CIDEA |
cell death-inducing DFFA-like effector a |
|
multiple interactions |
ISO |
18 |
12,254,318 |
12,277,594 |
RGD:6480464 |
CTD |
| G |
CIDEB |
cell death-inducing DFFA-like effector b |
|
increases expression |
EXP |
14 |
24,774,393 |
24,780,576 |
RGD:6480464 |
CTD |
| G |
CIDEB |
cell death-inducing DFFA-like effector b |
|
increases expression |
ISO |
14 |
24,774,393 |
24,780,576 |
RGD:6480464 |
CTD |
| G |
CIDEC |
cell death-inducing DFFA-like effector c |
|
decreases expression |
EXP |
3 |
9,908,394 |
9,921,938 |
RGD:6480464 |
CTD |
| G |
CIDEC |
cell death-inducing DFFA-like effector c |
|
increases expression |
ISO |
3 |
9,908,394 |
9,921,938 |
RGD:6480464 |
CTD |
| G |
CIRBP |
cold inducible RNA binding protein |
|
multiple interactions |
ISO |
19 |
1,269,267 |
1,274,809 |
RGD:6480464 |
CTD |
| G |
CIRBP |
cold inducible RNA binding protein |
|
decreases expression |
ISO |
19 |
1,269,267 |
1,274,809 |
RGD:6480464 |
CTD |
| G |
CISD2 |
CDGSH iron sulfur domain 2 |
|
increases expression |
ISO |
4 |
103,790,135 |
103,813,964 |
RGD:6480464 |
CTD |
| G |
CISH |
cytokine inducible SH2-containing protein |
|
multiple interactions |
ISO |
3 |
50,643,885 |
50,649,262 |
RGD:6480464 |
CTD |
| G |
CISH |
cytokine inducible SH2-containing protein |
|
increases expression |
ISO |
3 |
50,643,885 |
50,649,262 |
RGD:6480464 |
CTD |
| G |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions |
EXP |
6 |
139,693,392 |
139,695,787 |
RGD:6480464 |
CTD |
| G |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions |
EXP |
6 |
139,693,392 |
139,695,787 |
RGD:6480464 |
CTD |
| G |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
decreases expression |
EXP |
6 |
139,693,392 |
139,695,787 |
RGD:6480464 |
CTD |
| G |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions |
ISO |
6 |
139,693,392 |
139,695,787 |
RGD:6480464 |
CTD |
| G |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions |
ISO |
6 |
139,693,392 |
139,695,787 |
RGD:6480464 |
CTD |
| G |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
decreases expression |
ISO |
6 |
139,693,392 |
139,695,787 |
RGD:6480464 |
CTD |
| G |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
decreases expression |
ISO |
6 |
139,693,392 |
139,695,787 |
RGD:6480464 |
CTD |
| G |
CITED4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
|
multiple interactions |
ISO |
1 |
41,326,728 |
41,328,018 |
RGD:6480464 |
CTD |
| G |
CKB |
creatine kinase, brain |
|
increases expression |
ISO |
14 |
103,985,995 |
103,989,196 |
RGD:6480464 |
CTD |
| G |
CKB |
creatine kinase, brain |
|
multiple interactions |
ISO |
14 |
103,985,995 |
103,989,196 |
RGD:6480464 |
CTD |
| G |
CKM |
creatine kinase, muscle |
|
multiple interactions |
ISO |
19 |
45,809,671 |
45,826,235 |
RGD:6480464 |
CTD |
| G |
CKMT1B |
creatine kinase, mitochondrial 1B |
|
multiple interactions |
ISO |
15 |
43,885,252 |
43,891,604 |
RGD:6480464 |
CTD |
| G |
CKMT1B |
creatine kinase, mitochondrial 1B |
|
increases expression |
ISO |
15 |
43,885,252 |
43,891,604 |
RGD:6480464 |
CTD |
| G |
CKMT2 |
creatine kinase, mitochondrial 2 (sarcomeric) |
|
multiple interactions |
ISO |
5 |
80,529,139 |
80,562,217 |
RGD:6480464 |
CTD |
| G |
CKS1B |
CDC28 protein kinase regulatory subunit 1B |
|
multiple interactions |
EXP |
1 |
154,947,118 |
154,951,725 |
RGD:6480464 |
CTD |
| G |
CKS1B |
CDC28 protein kinase regulatory subunit 1B |
|
multiple interactions |
ISO |
1 |
154,947,118 |
154,951,725 |
RGD:6480464 |
CTD |
| G |
CKS2 |
CDC28 protein kinase regulatory subunit 2 |
|
multiple interactions |
ISO |
9 |
91,926,113 |
91,931,618 |
RGD:6480464 |
CTD |
| G |
CLCA1 |
chloride channel accessory 1 |
|
increases expression |
ISO |
1 |
86,934,526 |
86,965,977 |
RGD:6480464 |
CTD |
| G |
CLEC2D |
C-type lectin domain family 2, member D |
|
multiple interactions |
ISO |
12 |
9,822,304 |
9,852,151 |
RGD:6480464 |
CTD |
| G |
CLEC2D |
C-type lectin domain family 2, member D |
|
increases expression |
ISO |
12 |
9,822,304 |
9,852,151 |
RGD:6480464 |
CTD |
| G |
CLU |
clusterin |
|
decreases expression |
EXP |
8 |
27,454,434 |
27,472,328 |
RGD:6480464 |
CTD |
| G |
CLU |
clusterin |
|
increases expression |
ISO |
8 |
27,454,434 |
27,472,328 |
RGD:6480464 |
CTD |
| G |
CMAS |
cytidine monophosphate N-acetylneuraminic acid synthetase |
|
multiple interactions |
ISO |
12 |
22,199,110 |
22,218,608 |
RGD:6480464 |
CTD |
| G |
CMBL |
carboxymethylenebutenolidase homolog (Pseudomonas) |
|
decreases expression |
ISO |
5 |
10,277,707 |
10,308,168 |
RGD:6480464 |
CTD |
| G |
CMPK1 |
cytidine monophosphate (UMP-CMP) kinase 1, cytosolic |
|
decreases expression |
ISO |
1 |
47,799,469 |
47,844,511 |
RGD:6480464 |
CTD |
| G |
CMTM3 |
CKLF-like MARVEL transmembrane domain containing 3 |
|
increases expression |
EXP |
16 |
66,637,935 |
66,647,795 |
RGD:6480464 |
CTD |
| G |
CMTM7 |
CKLF-like MARVEL transmembrane domain containing 7 |
|
multiple interactions |
ISO |
3 |
32,433,163 |
32,496,333 |
RGD:6480464 |
CTD |
| G |
CMTM7 |
CKLF-like MARVEL transmembrane domain containing 7 |
|
increases expression |
ISO |
3 |
32,433,163 |
32,496,333 |
RGD:6480464 |
CTD |
| G |
CMTM8 |
CKLF-like MARVEL transmembrane domain containing 8 |
|
multiple interactions |
ISO |
3 |
32,280,171 |
32,411,813 |
RGD:6480464 |
CTD |
| G |
CMTM8 |
CKLF-like MARVEL transmembrane domain containing 8 |
|
decreases expression |
ISO |
3 |
32,280,171 |
32,411,813 |
RGD:6480464 |
CTD |
| G |
CNDP2 |
CNDP dipeptidase 2 (metallopeptidase M20 family) |
|
increases expression |
ISO |
18 |
72,163,500 |
72,190,689 |
RGD:6480464 |
CTD |
| G |
CNGA2 |
cyclic nucleotide gated channel alpha 2 |
|
multiple interactions |
ISO |
X |
150,903,218 |
150,914,036 |
RGD:6480464 |
CTD |
| G |
CNGA2 |
cyclic nucleotide gated channel alpha 2 |
|
multiple interactions |
ISO |
X |
150,903,218 |
150,914,036 |
RGD:6480464 |
CTD |
| G |
CNIH |
cornichon homolog (Drosophila) |
|
multiple interactions |
ISO |
14 |
54,893,647 |
54,908,148 |
RGD:6480464 |
CTD |
| G |
CNIH |
cornichon homolog (Drosophila) |
|
increases expression |
ISO |
14 |
54,893,647 |
54,908,148 |
RGD:6480464 |
CTD |
| G |
CNIH |
cornichon homolog (Drosophila) |
|
decreases expression |
EXP |
14 |
54,893,647 |
54,908,148 |
RGD:6480464 |
CTD |
| G |
CNIH2 |
cornichon homolog 2 (Drosophila) |
|
multiple interactions |
ISO |
11 |
66,045,672 |
66,051,685 |
RGD:6480464 |
CTD |
| G |
CNIH2 |
cornichon homolog 2 (Drosophila) |
|
increases expression |
ISO |
11 |
66,045,672 |
66,051,685 |
RGD:6480464 |
CTD |
| G |
CNN1 |
calponin 1, basic, smooth muscle |
|
increases expression |
EXP |
19 |
11,649,579 |
11,661,138 |
RGD:6480464 |
CTD |
| G |
CNN1 |
calponin 1, basic, smooth muscle |
|
multiple interactions |
ISO |
19 |
11,649,579 |
11,661,138 |
RGD:6480464 |
CTD |
| G |
CNN3 |
calponin 3, acidic |
|
increases expression |
ISO |
1 |
95,362,507 |
95,392,735 |
RGD:6480464 |
CTD |
| G |
CNNM2 |
cyclin M2 |
|
multiple interactions |
ISO |
10 |
104,678,075 |
104,838,344 |
RGD:6480464 |
CTD |
| G |
CNOT1 |
CCR4-NOT transcription complex, subunit 1 |
|
increases expression |
EXP |
16 |
58,553,850 |
58,663,790 |
RGD:6480464 |
CTD |
| G |
CNOT4 |
CCR4-NOT transcription complex, subunit 4 |
|
multiple interactions |
ISO |
7 |
135,046,547 |
135,194,875 |
RGD:6480464 |
CTD |
| G |
CNOT4 |
CCR4-NOT transcription complex, subunit 4 |
|
increases expression |
ISO |
7 |
135,046,547 |
135,194,875 |
RGD:6480464 |
CTD |
| G |
CNPY2 |
canopy 2 homolog (zebrafish) |
|
multiple interactions |
ISO |
12 |
56,704,212 |
56,710,128 |
RGD:6480464 |
CTD |
| G |
CNPY2 |
canopy 2 homolog (zebrafish) |
|
increases expression |
ISO |
12 |
56,704,212 |
56,710,128 |
RGD:6480464 |
CTD |
| G |
CNR2 |
cannabinoid receptor 2 (macrophage) |
|
multiple interactions |
ISO |
1 |
24,200,460 |
24,239,817 |
RGD:6480464 |
CTD |
| G |
CNTNAP2 |
contactin associated protein-like 2 |
|
multiple interactions |
ISO |
7 |
145,813,453 |
148,118,090 |
RGD:6480464 |
CTD |
| G |
CNTRL |
centriolin |
|
decreases expression |
ISO |
9 |
123,850,574 |
123,939,886 |
RGD:6480464 |
CTD |
| G |
COBL |
cordon-bleu WH2 repeat protein |
|
decreases expression |
ISO |
7 |
51,083,909 |
51,384,515 |
RGD:6480464 |
CTD |
| G |
COBLL1 |
cordon-bleu WH2 repeat protein-like 1 |
|
decreases expression |
EXP |
2 |
165,541,256 |
165,697,928 |
RGD:6480464 |
CTD |
| G |
COG6 |
component of oligomeric golgi complex 6 |
|
decreases expression |
EXP |
13 |
40,229,764 |
40,365,802 |
RGD:6480464 |
CTD |
| G |
COG8 |
component of oligomeric golgi complex 8 |
|
multiple interactions |
ISO |
16 |
69,362,524 |
69,373,526 |
RGD:6480464 |
CTD |
| G |
COL11A1 |
collagen, type XI, alpha 1 |
|
affects expression |
ISO |
1 |
103,342,023 |
103,574,052 |
RGD:6480464 |
CTD |
| G |
COL11A1 |
collagen, type XI, alpha 1 |
|
increases expression |
ISO |
1 |
103,342,023 |
103,574,052 |
RGD:6480464 |
CTD |
| G |
COL11A1 |
collagen, type XI, alpha 1 |
|
multiple interactions |
ISO |
1 |
103,342,023 |
103,574,052 |
RGD:6480464 |
CTD |
| G |
COL12A1 |
collagen, type XII, alpha 1 |
|
affects expression |
ISO |
6 |
75,794,042 |
75,915,623 |
RGD:6480464 |
CTD |
| G |
COL13A1 |
collagen, type XIII, alpha 1 |
|
increases expression |
EXP |
10 |
71,561,644 |
71,718,904 |
RGD:6480464 |
CTD |
| G |
COL13A1 |
collagen, type XIII, alpha 1 |
|
multiple interactions |
ISO |
10 |
71,561,644 |
71,718,904 |
RGD:6480464 |
CTD |
| G |
COL13A1 |
collagen, type XIII, alpha 1 |
|
increases expression |
ISO |
10 |
71,561,644 |
71,718,904 |
RGD:6480464 |
CTD |
| G |
COL14A1 |
collagen, type XIV, alpha 1 |
|
affects expression |
ISO |
8 |
121,137,352 |
121,384,273 |
RGD:6480464 |
CTD |
| G |
COL15A1 |
collagen, type XV, alpha 1 |
|
affects expression |
ISO |
9 |
101,706,138 |
101,833,068 |
RGD:6480464 |
CTD |
| G |
COL15A1 |
collagen, type XV, alpha 1 |
|
multiple interactions |
ISO |
9 |
101,706,138 |
101,833,068 |
RGD:6480464 |
CTD |
| G |
COL15A1 |
collagen, type XV, alpha 1 |
|
multiple interactions |
ISO |
9 |
101,706,138 |
101,833,068 |
RGD:6480464 |
CTD |
| G |
COL18A1 |
collagen, type XVIII, alpha 1 |
|
multiple interactions |
ISO |
21 |
46,825,097 |
46,933,634 |
RGD:6480464 |
CTD |
| G |
COL18A1 |
collagen, type XVIII, alpha 1 |
|
decreases expression |
ISO |
21 |
46,825,097 |
46,933,634 |
RGD:6480464 |
CTD |
| G |
COL18A1 |
collagen, type XVIII, alpha 1 |
|
decreases expression |
ISO |
21 |
46,825,097 |
46,933,634 |
RGD:6480464 |
CTD |
| G |
COL19A1 |
collagen, type XIX, alpha 1 |
|
multiple interactions |
ISO |
6 |
70,576,448 |
70,922,157 |
RGD:6480464 |
CTD |
| G |
COL19A1 |
collagen, type XIX, alpha 1 |
|
increases expression |
ISO |
6 |
70,576,448 |
70,922,157 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
affects expression |
ISO |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COL1A2 |
collagen, type I, alpha 2 |
|
multiple interactions |
ISO |
7 |
94,023,873 |
94,060,544 |
RGD:6480464 |
CTD |
| G |
COL1A2 |
collagen, type I, alpha 2 |
|
decreases expression |
ISO |
7 |
94,023,873 |
94,060,544 |
RGD:6480464 |
CTD |
| G |
COQ6 |
coenzyme Q6 homolog, monooxygenase (S. cerevisiae) |
|
increases expression |
ISO |
14 |
74,416,637 |
74,429,815 |
RGD:6480464 |
CTD |
| G |
COQ7 |
coenzyme Q7 homolog, ubiquinone (yeast) |
|
multiple interactions |
ISO |
16 |
19,078,917 |
19,091,417 |
RGD:6480464 |
CTD |
| G |
CORO1B |
coronin, actin binding protein, 1B |
|
multiple interactions |
ISO |
11 |
67,205,518 |
67,211,292 |
RGD:6480464 |
CTD |
| G |
CORO1B |
coronin, actin binding protein, 1B |
|
increases expression |
EXP |
11 |
67,205,518 |
67,211,292 |
RGD:6480464 |
CTD |
| G |
CORO2B |
coronin, actin binding protein, 2B |
|
multiple interactions |
ISO |
15 |
68,871,308 |
69,020,145 |
RGD:6480464 |
CTD |
| G |
CORO7 |
coronin 7 |
|
affects expression |
ISO |
16 |
4,404,543 |
4,466,962 |
RGD:6480464 |
CTD |
| G |
CORO7 |
coronin 7 |
|
multiple interactions |
ISO |
16 |
4,404,543 |
4,466,962 |
RGD:6480464 |
CTD |
| G |
CORT |
cortistatin |
|
multiple interactions |
ISO |
1 |
10,509,776 |
10,512,060 |
RGD:6480464 |
CTD |
| G |
COTL1 |
coactosin-like 1 (Dictyostelium) |
|
decreases expression |
EXP |
16 |
84,599,202 |
84,651,669 |
RGD:6480464 |
CTD |
| G |
COTL1 |
coactosin-like 1 (Dictyostelium) |
|
decreases expression |
ISO |
16 |
84,599,202 |
84,651,669 |
RGD:6480464 |
CTD |
| G |
COTL1 |
coactosin-like 1 (Dictyostelium) |
|
affects expression |
ISO |
16 |
84,599,202 |
84,651,669 |
RGD:6480464 |
CTD |
| G |
COX19 |
cytochrome c oxidase assembly homolog 19 (S. cerevisiae) |
|
multiple interactions |
ISO |
7 |
1,004,486 |
1,015,235 |
RGD:6480464 |
CTD |
| G |
COX19 |
cytochrome c oxidase assembly homolog 19 (S. cerevisiae) |
|
increases expression |
ISO |
7 |
1,004,486 |
1,015,235 |
RGD:6480464 |
CTD |
| G |
COX4I1 |
cytochrome c oxidase subunit IV isoform 1 |
|
increases expression |
ISO |
16 |
85,833,173 |
85,840,608 |
RGD:6480464 |
CTD |
| G |
COX4I2 |
cytochrome c oxidase subunit IV isoform 2 (lung) |
|
increases expression |
ISO |
20 |
30,225,691 |
30,232,800 |
RGD:6480464 |
CTD |
| G |
COX5A |
cytochrome c oxidase subunit Va |
|
multiple interactions |
ISO |
15 |
75,212,616 |
75,230,495 |
RGD:6480464 |
CTD |
| G |
COX5A |
cytochrome c oxidase subunit Va |
|
increases expression |
ISO |
15 |
75,212,616 |
75,230,495 |
RGD:6480464 |
CTD |
| G |
COX5B |
cytochrome c oxidase subunit Vb |
|
multiple interactions |
ISO |
2 |
98,262,521 |
98,264,657 |
RGD:6480464 |
CTD |
| G |
COX5B |
cytochrome c oxidase subunit Vb |
|
increases expression |
ISO |
2 |
98,262,521 |
98,264,657 |
RGD:6480464 |
CTD |
| G |
COX6A1 |
cytochrome c oxidase subunit VIa polypeptide 1 |
|
increases expression |
ISO |
12 |
120,875,893 |
120,878,545 |
RGD:6480464 |
CTD |
| G |
COX6A2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
|
decreases expression |
ISO |
16 |
31,439,052 |
31,439,749 |
RGD:6480464 |
CTD |
| G |
COX6B1 |
cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) |
|
increases expression |
ISO |
19 |
36,139,125 |
36,149,686 |
RGD:6480464 |
CTD |
| G |
COX6B2 |
cytochrome c oxidase subunit VIb polypeptide 2 (testis) |
|
decreases expression |
ISO |
19 |
55,861,070 |
55,866,182 |
RGD:6480464 |
CTD |
| G |
COX6C |
cytochrome c oxidase subunit VIc |
|
multiple interactions |
ISO |
8 |
100,890,223 |
100,906,242 |
RGD:6480464 |
CTD |
| G |
COX6C |
cytochrome c oxidase subunit VIc |
|
increases expression |
ISO |
8 |
100,890,223 |
100,906,242 |
RGD:6480464 |
CTD |
| G |
COX7A2 |
cytochrome c oxidase subunit VIIa polypeptide 2 (liver) |
|
increases expression |
ISO |
6 |
75,947,391 |
75,953,644 |
RGD:6480464 |
CTD |
| G |
COX7A2L |
cytochrome c oxidase subunit VIIa polypeptide 2 like |
|
multiple interactions |
ISO |
2 |
42,577,642 |
42,588,356 |
RGD:6480464 |
CTD |
| G |
COX7B |
cytochrome c oxidase subunit VIIb |
|
increases expression |
ISO |
X |
77,154,961 |
77,160,881 |
RGD:6480464 |
CTD |
| G |
COX7C |
cytochrome c oxidase subunit VIIc |
|
multiple interactions |
ISO |
5 |
85,913,784 |
85,916,583 |
RGD:6480464 |
CTD |
| G |
CP |
ceruloplasmin (ferroxidase) |
|
multiple interactions |
EXP |
3 |
148,880,197 |
148,939,832 |
RGD:6480464 |
CTD |
| G |
CP |
ceruloplasmin (ferroxidase) |
|
decreases expression |
EXP |
3 |
148,880,197 |
148,939,832 |
RGD:6480464 |
CTD |
| G |
CP |
ceruloplasmin (ferroxidase) |
|
multiple interactions |
ISO |
3 |
148,880,197 |
148,939,832 |
RGD:6480464 |
CTD |
| G |
CP |
ceruloplasmin (ferroxidase) |
|
multiple interactions |
ISO |
3 |
148,880,197 |
148,939,832 |
RGD:6480464 |
CTD |
| G |
CP |
ceruloplasmin (ferroxidase) |
|
increases expression |
ISO |
3 |
148,880,197 |
148,939,832 |
RGD:6480464 |
CTD |
| G |
CP |
ceruloplasmin (ferroxidase) |
|
decreases expression |
ISO |
3 |
148,880,197 |
148,939,832 |
RGD:6480464 |
CTD |
| G |
CPA3 |
carboxypeptidase A3 (mast cell) |
|
multiple interactions |
ISO |
3 |
148,583,043 |
148,614,874 |
RGD:6480464 |
CTD |
| G |
CPA3 |
carboxypeptidase A3 (mast cell) |
|
decreases expression |
ISO |
3 |
148,583,043 |
148,614,874 |
RGD:6480464 |
CTD |
| G |
CPA5 |
carboxypeptidase A5 |
|
multiple interactions |
ISO |
7 |
129,984,630 |
130,008,571 |
RGD:6480464 |
CTD |
| G |
CPAMD8 |
C3 and PZP-like, alpha-2-macroglobulin domain containing 8 |
|
decreases expression |
ISO |
19 |
17,003,762 |
17,137,625 |
RGD:6480464 |
CTD |
| G |
CPB1 |
carboxypeptidase B1 (tissue) |
|
multiple interactions |
ISO |
3 |
148,545,588 |
148,577,974 |
RGD:6480464 |
CTD |
| G |
CPB2 |
carboxypeptidase B2 (plasma) |
|
increases expression |
ISO |
13 |
46,627,322 |
46,679,211 |
RGD:6480464 |
CTD |
| G |
CPB2 |
carboxypeptidase B2 (plasma) |
|
decreases expression |
EXP |
13 |
46,627,322 |
46,679,211 |
RGD:6480464 |
CTD |
| G |
CPD |
carboxypeptidase D |
|
multiple interactions |
ISO |
17 |
28,705,942 |
28,796,675 |
RGD:6480464 |
CTD |
| G |
CPD |
carboxypeptidase D |
|
decreases expression |
ISO |
17 |
28,705,942 |
28,796,675 |
RGD:6480464 |
CTD |
| G |
CPE |
carboxypeptidase E |
|
multiple interactions |
EXP |
4 |
166,300,097 |
166,419,482 |
RGD:6480464 |
CTD |
| G |
CPE |
carboxypeptidase E |
|
multiple interactions |
ISO |
4 |
166,300,097 |
166,419,482 |
RGD:6480464 |
CTD |
| G |
CPE |
carboxypeptidase E |
|
decreases expression |
EXP |
4 |
166,300,097 |
166,419,482 |
RGD:6480464 |
CTD |
| G |
CPEB2 |
cytoplasmic polyadenylation element binding protein 2 |
|
increases expression |
EXP |
4 |
15,004,298 |
15,071,777 |
RGD:6480464 |
CTD |
| G |
CPEB2 |
cytoplasmic polyadenylation element binding protein 2 |
|
decreases expression |
ISO |
4 |
15,004,298 |
15,071,777 |
RGD:6480464 |
CTD |
| G |
CPEB3 |
cytoplasmic polyadenylation element binding protein 3 |
|
decreases expression |
EXP |
10 |
93,808,397 |
94,050,875 |
RGD:6480464 |
CTD |
| G |
CPEB4 |
cytoplasmic polyadenylation element binding protein 4 |
|
affects expression |
ISO |
5 |
173,315,331 |
173,387,313 |
RGD:6480464 |
CTD |
| G |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
|
decreases expression |
EXP |
7 |
120,628,751 |
120,937,498 |
RGD:6480464 |
CTD |
| G |
CPLX1 |
complexin 1 |
|
decreases expression |
ISO |
4 |
778,745 |
819,945 |
RGD:6480464 |
CTD |
| G |
CPN1 |
carboxypeptidase N, polypeptide 1 |
|
multiple interactions |
ISO |
10 |
101,802,065 |
101,841,642 |
RGD:6480464 |
CTD |
| G |
CPN2 |
carboxypeptidase N, polypeptide 2 |
|
multiple interactions |
ISO |
3 |
194,060,494 |
194,072,057 |
RGD:6480464 |
CTD |
| G |
CPNE2 |
copine II |
|
multiple interactions |
ISO |
16 |
57,126,455 |
57,181,878 |
RGD:6480464 |
CTD |
| G |
CPNE2 |
copine II |
|
increases expression |
EXP |
16 |
57,126,455 |
57,181,878 |
RGD:6480464 |
CTD |
| G |
CR1L |
complement component (3b/4b) receptor 1-like |
|
decreases expression |
ISO |
1 |
207,818,458 |
207,897,036 |
RGD:6480464 |
CTD |
| G |
CRY1 |
cryptochrome 1 (photolyase-like) |
|
decreases expression |
EXP |
12 |
107,385,142 |
107,487,635 |
RGD:6480464 |
CTD |
| G |
CRY1 |
cryptochrome 1 (photolyase-like) |
|
multiple interactions |
ISO |
12 |
107,385,142 |
107,487,635 |
RGD:6480464 |
CTD |
| G |
CRY1 |
cryptochrome 1 (photolyase-like) |
|
increases expression |
ISO |
12 |
107,385,142 |
107,487,635 |
RGD:6480464 |
CTD |
| G |
CRY2 |
cryptochrome 2 (photolyase-like) |
|
increases expression |
ISO |
11 |
45,868,669 |
45,904,799 |
RGD:6480464 |
CTD |
| G |
CRYAA |
crystallin, alpha A |
|
multiple interactions |
ISO |
21 |
44,589,141 |
44,592,913 |
RGD:6480464 |
CTD |
| G |
CRYAB |
crystallin, alpha B |
|
multiple interactions |
ISO |
11 |
111,779,350 |
111,782,473 |
RGD:6480464 |
CTD |
| G |
CRYBA1 |
crystallin, beta A1 |
|
multiple interactions |
ISO |
17 |
27,573,875 |
27,581,512 |
RGD:6480464 |
CTD |
| G |
CRYBA2 |
crystallin, beta A2 |
|
multiple interactions |
ISO |
2 |
219,854,912 |
219,858,127 |
RGD:6480464 |
CTD |
| G |
CRYGB |
crystallin, gamma B |
|
multiple interactions |
ISO |
2 |
209,007,297 |
209,010,877 |
RGD:6480464 |
CTD |
| G |
CRYGN |
crystallin, gamma N |
|
multiple interactions |
ISO |
7 |
151,127,056 |
151,137,099 |
RGD:6480464 |
CTD |
| G |
CRYGS |
crystallin, gamma S |
|
multiple interactions |
ISO |
3 |
186,256,232 |
186,262,167 |
RGD:6480464 |
CTD |
| G |
CRYL1 |
crystallin, lambda 1 |
|
multiple interactions |
EXP |
13 |
20,977,806 |
21,100,012 |
RGD:6480464 |
CTD |
| G |
CRYL1 |
crystallin, lambda 1 |
|
increases expression |
EXP |
13 |
20,977,806 |
21,100,012 |
RGD:6480464 |
CTD |
| G |
CRYL1 |
crystallin, lambda 1 |
|
multiple interactions |
ISO |
13 |
20,977,806 |
21,100,012 |
RGD:6480464 |
CTD |
| G |
CRYZ |
crystallin, zeta (quinone reductase) |
|
decreases expression |
EXP |
1 |
75,171,170 |
75,199,092 |
RGD:6480464 |
CTD |
| G |
CRYZ |
crystallin, zeta (quinone reductase) |
|
multiple interactions |
ISO |
1 |
75,171,170 |
75,199,092 |
RGD:6480464 |
CTD |
| G |
CRYZ |
crystallin, zeta (quinone reductase) |
|
increases activity |
ISO |
1 |
75,171,170 |
75,199,092 |
RGD:6480464 |
CTD |
| G |
CRYZ |
crystallin, zeta (quinone reductase) |
|
increases expression |
ISO |
1 |
75,171,170 |
75,199,092 |
RGD:6480464 |
CTD |
| G |
CS |
citrate synthase |
|
decreases expression |
EXP |
12 |
56,665,483 |
56,694,175 |
RGD:6480464 |
CTD |
| G |
CS |
citrate synthase |
|
multiple interactions |
ISO |
12 |
56,665,483 |
56,694,175 |
RGD:6480464 |
CTD |
| G |
CS |
citrate synthase |
|
multiple interactions |
ISO |
12 |
56,665,483 |
56,694,175 |
RGD:6480464 |
CTD |
| G |
CSAD |
cysteine sulfinic acid decarboxylase |
|
multiple interactions |
ISO |
12 |
53,551,447 |
53,574,693 |
RGD:6480464 |
CTD |
| G |
CSAD |
cysteine sulfinic acid decarboxylase |
|
decreases expression |
ISO |
12 |
53,551,447 |
53,574,693 |
RGD:6480464 |
CTD |
| G |
CSE1L |
CSE1 chromosome segregation 1-like (yeast) |
|
multiple interactions |
ISO |
20 |
47,662,783 |
47,713,497 |
RGD:6480464 |
CTD |
| G |
CSE1L |
CSE1 chromosome segregation 1-like (yeast) |
|
increases expression |
ISO |
20 |
47,662,783 |
47,713,497 |
RGD:6480464 |
CTD |
| G |
CSF1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
EXP |
1 |
110,453,233 |
110,473,616 |
RGD:6480464 |
CTD |
| G |
CSF1 |
colony stimulating factor 1 (macrophage) |
|
increases expression |
EXP |
1 |
110,453,233 |
110,473,616 |
RGD:6480464 |
CTD |
| G |
CSF1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
ISO |
1 |
110,453,233 |
110,473,616 |
RGD:6480464 |
CTD |
| G |
CSF1 |
colony stimulating factor 1 (macrophage) |
|
decreases expression |
ISO |
1 |
110,453,233 |
110,473,616 |
RGD:6480464 |
CTD |
| G |
CSF1R |
colony stimulating factor 1 receptor |
|
multiple interactions |
ISO |
5 |
149,432,854 |
149,492,935 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
ISO |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CSF2RB |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
|
increases expression |
ISO |
22 |
37,309,675 |
37,336,481 |
RGD:6480464 |
CTD |
| G |
CSF3 |
colony stimulating factor 3 (granulocyte) |
|
increases expression |
ISO |
17 |
38,171,614 |
38,174,066 |
RGD:6480464 |
CTD |
| G |
CSGALNACT2 |
chondroitin sulfate N-acetylgalactosaminyltransferase 2 |
|
decreases expression |
EXP |
10 |
43,633,934 |
43,680,750 |
RGD:6480464 |
CTD |
| G |
CSK |
c-src tyrosine kinase |
|
increases expression |
ISO |
15 |
75,074,425 |
75,095,539 |
RGD:6480464 |
CTD |
| G |
CSN2 |
casein beta |
|
decreases expression |
ISO |
4 |
70,820,974 |
70,826,726 |
RGD:6480464 |
CTD |
| G |
CSNK1A1 |
casein kinase 1, alpha 1 |
|
decreases expression |
ISO |
5 |
148,874,845 |
148,931,007 |
RGD:6480464 |
CTD |
| G |
CSNK1D |
casein kinase 1, delta |
|
multiple interactions |
EXP |
17 |
80,200,537 |
80,231,594 |
RGD:6480464 |
CTD |
| G |
CSNK1D |
casein kinase 1, delta |
|
decreases expression |
EXP |
17 |
80,200,537 |
80,231,594 |
RGD:6480464 |
CTD |
| G |
CSNK1G1 |
casein kinase 1, gamma 1 |
|
multiple interactions |
ISO |
15 |
64,457,716 |
64,648,442 |
RGD:6480464 |
CTD |
| G |
CSNK1G1 |
casein kinase 1, gamma 1 |
|
increases expression |
ISO |
15 |
64,457,716 |
64,648,442 |
RGD:6480464 |
CTD |
| G |
CSNK1G3 |
casein kinase 1, gamma 3 |
|
multiple interactions |
ISO |
5 |
122,847,793 |
122,952,739 |
RGD:6480464 |
CTD |
| G |
CSNK2A1 |
casein kinase 2, alpha 1 polypeptide |
|
affects expression |
ISO |
20 |
463,338 |
524,482 |
RGD:6480464 |
CTD |
| G |
CSNK2A1 |
casein kinase 2, alpha 1 polypeptide |
|
multiple interactions |
ISO |
20 |
463,338 |
524,482 |
RGD:6480464 |
CTD |
| G |
CSNK2A1 |
casein kinase 2, alpha 1 polypeptide |
|
increases expression |
ISO |
20 |
463,338 |
524,482 |
RGD:6480464 |
CTD |
| G |
CSNK2A2 |
casein kinase 2, alpha prime polypeptide |
|
multiple interactions |
ISO |
16 |
58,191,811 |
58,231,782 |
RGD:6480464 |
CTD |
| G |
CSNK2A2 |
casein kinase 2, alpha prime polypeptide |
|
increases expression |
ISO |
16 |
58,191,811 |
58,231,782 |
RGD:6480464 |
CTD |
| G |
CSNK2B |
casein kinase 2, beta polypeptide |
|
affects expression |
ISO |
6 |
31,633,657 |
31,637,843 |
RGD:6480464 |
CTD |
| G |
CSNK2B |
casein kinase 2, beta polypeptide |
|
multiple interactions |
ISO |
6 |
31,633,657 |
31,637,843 |
RGD:6480464 |
CTD |
| G |
CSPG5 |
chondroitin sulfate proteoglycan 5 (neuroglycan C) |
|
decreases expression |
ISO |
3 |
47,603,728 |
47,621,730 |
RGD:6480464 |
CTD |
| G |
CSRNP1 |
cysteine-serine-rich nuclear protein 1 |
|
decreases expression |
ISO |
3 |
39,183,342 |
39,195,102 |
RGD:6480464 |
CTD |
| G |
CTSD |
cathepsin D |
|
multiple interactions |
EXP |
11 |
1,773,982 |
1,785,222 |
RGD:6480464 |
CTD |
| G |
CTSD |
cathepsin D |
|
decreases expression |
EXP |
11 |
1,773,982 |
1,785,222 |
RGD:6480464 |
CTD |
| G |
CTSD |
cathepsin D |
|
increases expression |
ISO |
11 |
1,773,982 |
1,785,222 |
RGD:6480464 |
CTD |
| G |
CTSG |
cathepsin G |
|
increases expression |
ISO |
14 |
25,042,724 |
25,045,466 |
RGD:6480464 |
CTD |
| G |
CTSH |
cathepsin H |
|
multiple interactions |
ISO |
15 |
79,214,092 |
79,237,420 |
RGD:6480464 |
CTD |
| G |
CTSL1 |
cathepsin L1 |
|
multiple interactions |
ISO |
9 |
90,340,974 |
90,346,384 |
RGD:6480464 |
CTD |
| G |
CTSL1 |
cathepsin L1 |
|
affects expression |
ISO |
9 |
90,340,974 |
90,346,384 |
RGD:6480464 |
CTD |
| G |
CTSL1 |
cathepsin L1 |
|
multiple interactions |
ISO |
9 |
90,340,974 |
90,346,384 |
RGD:6480464 |
CTD |
| G |
CTSL1 |
cathepsin L1 |
|
multiple interactions |
ISO |
9 |
90,340,974 |
90,346,384 |
RGD:6480464 |
CTD |
| G |
CTSL1 |
cathepsin L1 |
|
increases expression |
ISO |
9 |
90,340,974 |
90,346,384 |
RGD:6480464 |
CTD |
| G |
CTSL1 |
cathepsin L1 |
|
decreases expression |
ISO |
9 |
90,340,974 |
90,346,384 |
RGD:6480464 |
CTD |
| G |
CTSL1 |
cathepsin L1 |
|
increases expression |
ISO |
9 |
90,340,974 |
90,346,384 |
RGD:6480464 |
CTD |
| G |
CTSL1 |
cathepsin L1 |
|
increases expression |
ISO |
9 |
90,340,974 |
90,346,384 |
RGD:6480464 |
CTD |
| G |
CTSL1 |
cathepsin L1 |
|
increases expression |
ISO |
9 |
90,340,974 |
90,346,384 |
RGD:6480464 |
CTD |
| G |
CTSS |
cathepsin S |
|
increases expression |
EXP |
1 |
150,702,672 |
150,738,433 |
RGD:6480464 |
CTD |
| G |
CTSS |
cathepsin S |
|
multiple interactions |
ISO |
1 |
150,702,672 |
150,738,433 |
RGD:6480464 |
CTD |
| G |
CTSW |
cathepsin W |
|
multiple interactions |
ISO |
11 |
65,647,284 |
65,651,212 |
RGD:6480464 |
CTD |
| G |
CTSZ |
cathepsin Z |
|
multiple interactions |
ISO |
20 |
57,570,242 |
57,582,309 |
RGD:6480464 |
CTD |
| G |
CTXN1 |
cortexin 1 |
|
decreases expression |
ISO |
19 |
7,989,381 |
7,991,051 |
RGD:6480464 |
CTD |
| G |
CTXN1 |
cortexin 1 |
|
increases expression |
ISO |
19 |
7,989,381 |
7,991,051 |
RGD:6480464 |
CTD |
| G |
CUEDC1 |
CUE domain containing 1 |
|
increases expression |
EXP |
17 |
55,940,337 |
55,980,750 |
RGD:6480464 |
CTD |
| G |
CUL2 |
cullin 2 |
|
increases expression |
EXP |
10 |
35,297,479 |
35,379,570 |
RGD:6480464 |
CTD |
| G |
CUL3 |
cullin 3 |
|
decreases expression |
ISO |
2 |
225,334,867 |
225,450,114 |
RGD:6480464 |
CTD |
| G |
CUL4B |
cullin 4B |
|
increases expression |
ISO |
X |
119,658,444 |
119,709,684 |
RGD:6480464 |
CTD |
| G |
CUTA |
cutA divalent cation tolerance homolog (E. coli) |
|
decreases expression |
ISO |
6 |
33,384,319 |
33,386,065 |
RGD:6480464 |
CTD |
| G |
CUTC |
cutC copper transporter homolog (E. coli) |
|
multiple interactions |
ISO |
10 |
101,491,958 |
101,515,894 |
RGD:6480464 |
CTD |
| G |
CUX1 |
cut-like homeobox 1 |
|
multiple interactions |
ISO |
7 |
101,459,184 |
101,927,250 |
RGD:6480464 |
CTD |
| G |
CUX1 |
cut-like homeobox 1 |
|
multiple interactions |
ISO |
7 |
101,459,184 |
101,927,250 |
RGD:6480464 |
CTD |
| G |
CUX2 |
cut-like homeobox 2 |
|
decreases expression |
EXP |
12 |
111,471,828 |
111,788,358 |
RGD:6480464 |
CTD |
| G |
CUX2 |
cut-like homeobox 2 |
|
multiple interactions |
ISO |
12 |
111,471,828 |
111,788,358 |
RGD:6480464 |
CTD |
| G |
CX3CL1 |
chemokine (C-X3-C motif) ligand 1 |
|
multiple interactions |
ISO |
16 |
57,406,414 |
57,418,956 |
RGD:6480464 |
CTD |
| G |
CX3CL1 |
chemokine (C-X3-C motif) ligand 1 |
|
multiple interactions |
ISO |
16 |
57,406,414 |
57,418,956 |
RGD:6480464 |
CTD |
| G |
CX3CL1 |
chemokine (C-X3-C motif) ligand 1 |
|
decreases expression |
ISO |
16 |
57,406,414 |
57,418,956 |
RGD:6480464 |
CTD |
| G |
CXADR |
coxsackie virus and adenovirus receptor |
|
decreases expression |
EXP |
21 |
18,885,224 |
18,965,897 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
|
decreases expression |
EXP |
4 |
76,942,269 |
76,944,689 |
RGD:6480464 |
CTD |
| G |
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
ISO |
4 |
76,942,269 |
76,944,689 |
RGD:6480464 |
CTD |
| G |
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
ISO |
4 |
76,942,269 |
76,944,689 |
RGD:6480464 |
CTD |
| G |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
EXP |
10 |
44,865,605 |
44,880,545 |
RGD:6480464 |
CTD |
| G |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases expression |
EXP |
10 |
44,865,605 |
44,880,545 |
RGD:6480464 |
CTD |
| G |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases expression |
EXP |
10 |
44,865,605 |
44,880,545 |
RGD:6480464 |
CTD |
| G |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
|
increases expression |
EXP |
10 |
44,865,605 |
44,880,545 |
RGD:6480464 |
CTD |
| G |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
ISO |
10 |
44,865,605 |
44,880,545 |
RGD:6480464 |
CTD |
| G |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
ISO |
10 |
44,865,605 |
44,880,545 |
RGD:6480464 |
CTD |
| G |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
ISO |
10 |
44,865,605 |
44,880,545 |
RGD:6480464 |
CTD |
| G |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases expression |
ISO |
10 |
44,865,605 |
44,880,545 |
RGD:6480464 |
CTD |
| G |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
|
increases expression |
ISO |
10 |
44,865,605 |
44,880,545 |
RGD:6480464 |
CTD |
| G |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
|
increases expression |
ISO |
10 |
44,865,605 |
44,880,545 |
RGD:6480464 |
CTD |
| G |
CXCL13 |
chemokine (C-X-C motif) ligand 13 |
|
decreases expression |
EXP |
4 |
78,432,907 |
78,532,988 |
RGD:6480464 |
CTD |
| G |
CXCL13 |
chemokine (C-X-C motif) ligand 13 |
|
multiple interactions |
EXP |
4 |
78,432,907 |
78,532,988 |
RGD:6480464 |
CTD |
| G |
CXCL13 |
chemokine (C-X-C motif) ligand 13 |
|
increases expression |
ISO |
4 |
78,432,907 |
78,532,988 |
RGD:6480464 |
CTD |
| G |
CXCL14 |
chemokine (C-X-C motif) ligand 14 |
|
multiple interactions |
ISO |
5 |
134,906,369 |
134,914,969 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
EXP |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CYP11B1 |
cytochrome P450, family 11, subfamily B, polypeptide 1 |
|
decreases expression |
ISO |
8 |
143,953,773 |
143,961,236 |
RGD:6480464 |
CTD |
| G |
CYP11B2 |
cytochrome P450, family 11, subfamily B, polypeptide 2 |
|
decreases expression |
ISO |
8 |
143,991,975 |
143,999,259 |
RGD:6480464 |
CTD |
| G |
CYP17A1 |
cytochrome P450, family 17, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
10 |
104,590,288 |
104,597,290 |
RGD:6480464 |
CTD |
| G |
CYP17A1 |
cytochrome P450, family 17, subfamily A, polypeptide 1 |
|
decreases expression |
ISO |
10 |
104,590,288 |
104,597,290 |
RGD:6480464 |
CTD |
| G |
CYP17A1 |
cytochrome P450, family 17, subfamily A, polypeptide 1 |
|
decreases expression |
ISO |
10 |
104,590,288 |
104,597,290 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
affects activity |
EXP |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
increases expression |
EXP |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
increases activity |
EXP |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
increases expression |
EXP |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
increases stability |
EXP |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
affects expression |
ISO |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
decreases activity |
ISO |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
decreases expression |
ISO |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
increases expression |
ISO |
15 |
51,500,254 |
51,630,795 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases activity |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
multiple interactions |
ISO |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2C18 |
cytochrome P450, family 2, subfamily C, polypeptide 18 |
|
multiple interactions |
ISO |
10 |
96,443,251 |
96,495,947 |
RGD:6480464 |
CTD |
| G |
CYP2C9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
increases expression |
ISO |
10 |
96,698,415 |
96,749,148 |
RGD:6480464 |
CTD |
| G |
CYP2C9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
decreases activity |
ISO |
10 |
96,698,415 |
96,749,148 |
RGD:6480464 |
CTD |
| G |
CYP2C9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
multiple interactions |
ISO |
10 |
96,698,415 |
96,749,148 |
RGD:6480464 |
CTD |
| G |
CYP2C9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
increases expression |
ISO |
10 |
96,698,415 |
96,749,148 |
RGD:6480464 |
CTD |
| G |
CYP4F3 |
cytochrome P450, family 4, subfamily F, polypeptide 3 |
|
multiple interactions |
ISO |
19 |
15,751,707 |
15,771,570 |
RGD:6480464 |
CTD |
| G |
CYP4F8 |
cytochrome P450, family 4, subfamily F, polypeptide 8 |
|
multiple interactions |
ISO |
19 |
15,726,029 |
15,740,448 |
RGD:6480464 |
CTD |
| G |
CYP4F8 |
cytochrome P450, family 4, subfamily F, polypeptide 8 |
|
decreases expression |
ISO |
19 |
15,726,029 |
15,740,448 |
RGD:6480464 |
CTD |
| G |
CYP4F8 |
cytochrome P450, family 4, subfamily F, polypeptide 8 |
|
decreases expression |
ISO |
19 |
15,726,029 |
15,740,448 |
RGD:6480464 |
CTD |
| G |
CYP4F8 |
cytochrome P450, family 4, subfamily F, polypeptide 8 |
|
increases expression |
ISO |
19 |
15,726,029 |
15,740,448 |
RGD:6480464 |
CTD |
| G |
DIABLO |
diablo, IAP-binding mitochondrial protein |
|
affects expression |
ISO |
12 |
122,692,209 |
122,712,068 |
RGD:6480464 |
CTD |
| G |
DROSHA |
drosha, ribonuclease type III |
|
multiple interactions |
ISO |
5 |
31,400,601 |
31,532,282 |
RGD:6480464 |
CTD |
| G |
DSC1 |
desmocollin 1 |
|
increases expression |
ISO |
18 |
28,709,199 |
28,742,819 |
RGD:6480464 |
CTD |
| G |
DTNBP1 |
dystrobrevin binding protein 1 |
|
affects expression |
ISO |
6 |
15,523,032 |
15,663,289 |
RGD:6480464 |
CTD |
| G |
DTNBP1 |
dystrobrevin binding protein 1 |
|
increases expression |
ISO |
6 |
15,523,032 |
15,663,289 |
RGD:6480464 |
CTD |
| G |
DTNBP1 |
dystrobrevin binding protein 1 |
|
multiple interactions |
ISO |
6 |
15,523,032 |
15,663,289 |
RGD:6480464 |
CTD |
| G |
EAPP |
E2F-associated phosphoprotein |
|
multiple interactions |
ISO |
14 |
34,985,135 |
35,008,943 |
RGD:6480464 |
CTD |
| G |
EIF1 |
eukaryotic translation initiation factor 1 |
|
multiple interactions |
ISO |
17 |
39,845,127 |
39,847,898 |
RGD:6480464 |
CTD |
| G |
EMC8 |
ER membrane protein complex subunit 8 |
|
affects expression |
ISO |
16 |
85,812,230 |
85,833,148 |
RGD:6480464 |
CTD |
| G |
EMC8 |
ER membrane protein complex subunit 8 |
|
multiple interactions |
ISO |
16 |
85,812,230 |
85,833,148 |
RGD:6480464 |
CTD |
| G |
EMC8 |
ER membrane protein complex subunit 8 |
|
increases expression |
ISO |
16 |
85,812,230 |
85,833,148 |
RGD:6480464 |
CTD |
| G |
ENHO |
energy homeostasis associated |
|
multiple interactions |
ISO |
9 |
34,521,040 |
34,523,037 |
RGD:6480464 |
CTD |
| G |
ERH |
enhancer of rudimentary homolog (Drosophila) |
|
multiple interactions |
ISO |
14 |
69,846,840 |
69,865,021 |
RGD:6480464 |
CTD |
| G |
ERH |
enhancer of rudimentary homolog (Drosophila) |
|
increases expression |
ISO |
14 |
69,846,840 |
69,865,021 |
RGD:6480464 |
CTD |
| G |
EVI5L |
ecotropic viral integration site 5-like |
|
affects expression |
ISO |
19 |
7,895,161 |
7,929,862 |
RGD:6480464 |
CTD |
| G |
FAM127B |
family with sequence similarity 127, member B |
|
multiple interactions |
ISO |
X |
134,184,962 |
134,186,221 |
RGD:6480464 |
CTD |
| G |
FAM213A |
family with sequence similarity 213, member A |
|
increases expression |
EXP |
10 |
82,167,585 |
82,192,753 |
RGD:6480464 |
CTD |
| G |
FAM213A |
family with sequence similarity 213, member A |
|
decreases expression |
EXP |
10 |
82,167,585 |
82,192,753 |
RGD:6480464 |
CTD |
| G |
FOXC2 |
forkhead box C2 (MFH-1, mesenchyme forkhead 1) |
|
affects expression |
ISO |
16 |
86,600,857 |
86,602,539 |
RGD:6480464 |
CTD |
| G |
FOXC2 |
forkhead box C2 (MFH-1, mesenchyme forkhead 1) |
|
multiple interactions |
ISO |
16 |
86,600,857 |
86,602,539 |
RGD:6480464 |
CTD |
| G |
FOXC2 |
forkhead box C2 (MFH-1, mesenchyme forkhead 1) |
|
decreases expression |
ISO |
16 |
86,600,857 |
86,602,539 |
RGD:6480464 |
CTD |
| G |
FOXP4 |
forkhead box P4 |
|
affects expression |
ISO |
6 |
41,514,164 |
41,570,122 |
RGD:6480464 |
CTD |
| G |
FOXP4 |
forkhead box P4 |
|
multiple interactions |
ISO |
6 |
41,514,164 |
41,570,122 |
RGD:6480464 |
CTD |
| G |
FZD7 |
frizzled family receptor 7 |
|
increases expression |
ISO |
2 |
202,899,310 |
202,903,160 |
RGD:6480464 |
CTD |
| G |
GRAMD1C |
GRAM domain containing 1C |
|
multiple interactions |
ISO |
3 |
113,557,681 |
113,666,021 |
RGD:6480464 |
CTD |
| G |
GSTA5 |
glutathione S-transferase alpha 5 |
|
increases expression |
ISO |
6 |
52,696,540 |
52,710,893 |
RGD:6480464 |
CTD |
| G |
HBG1 |
hemoglobin, gamma A |
|
increases expression |
ISO |
11 |
5,269,502 |
5,271,087 |
RGD:6480464 |
CTD |
| G |
HIST1H2BL |
histone cluster 1, H2bl |
|
decreases expression |
ISO |
6 |
27,775,257 |
27,775,709 |
RGD:6480464 |
CTD |
| G |
HIST1H2BO |
histone cluster 1, H2bo |
|
affects expression |
ISO |
6 |
27,861,203 |
27,861,669 |
RGD:6480464 |
CTD |
| G |
HLA-C |
major histocompatibility complex, class I, C |
|
multiple interactions |
ISO |
6 |
31,236,526 |
31,239,913 |
RGD:6480464 |
CTD |
| G |
HLA-C |
major histocompatibility complex, class I, C |
|
increases expression |
ISO |
6 |
31,236,526 |
31,239,913 |
RGD:6480464 |
CTD |
| G |
HSPA1A |
heat shock 70kDa protein 1A |
|
multiple interactions |
ISO |
6 |
31,783,291 |
31,785,719 |
RGD:6480464 |
CTD |
| G |
HSPA1A |
heat shock 70kDa protein 1A |
|
increases expression |
ISO |
6 |
31,783,291 |
31,785,719 |
RGD:6480464 |
CTD |
| G |
HSPA1A |
heat shock 70kDa protein 1A |
|
affects expression |
ISO |
6 |
31,783,291 |
31,785,719 |
RGD:6480464 |
CTD |
| G |
HSPA1A |
heat shock 70kDa protein 1A |
|
multiple interactions |
ISO |
6 |
31,783,291 |
31,785,719 |
RGD:6480464 |
CTD |
| G |
HSPE1 |
heat shock 10kDa protein 1 (chaperonin 10) |
|
multiple interactions |
ISO |
2 |
198,364,721 |
198,368,187 |
RGD:6480464 |
CTD |
| G |
HSPE1 |
heat shock 10kDa protein 1 (chaperonin 10) |
|
increases expression |
ISO |
2 |
198,364,721 |
198,368,187 |
RGD:6480464 |
CTD |
| G |
HSPG2 |
heparan sulfate proteoglycan 2 |
|
affects expression |
ISO |
1 |
22,148,737 |
22,263,750 |
RGD:6480464 |
CTD |
| G |
HSPG2 |
heparan sulfate proteoglycan 2 |
|
increases expression |
ISO |
1 |
22,148,737 |
22,263,750 |
RGD:6480464 |
CTD |
| G |
ICOS |
inducible T-cell co-stimulator |
|
affects expression |
ISO |
2 |
204,801,471 |
204,826,300 |
RGD:6480464 |
CTD |
| G |
ICOS |
inducible T-cell co-stimulator |
|
increases expression |
ISO |
2 |
204,801,471 |
204,826,300 |
RGD:6480464 |
CTD |
| G |
IFIT3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
increases expression |
ISO |
10 |
91,087,602 |
91,100,725 |
RGD:6480464 |
CTD |
| G |
IPO11 |
importin 11 |
|
affects expression |
ISO |
5 |
61,708,573 |
61,924,416 |
RGD:6480464 |
CTD |
| G |
IPO11 |
importin 11 |
|
multiple interactions |
ISO |
5 |
61,708,573 |
61,924,416 |
RGD:6480464 |
CTD |
| G |
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
|
affects expression |
ISO |
17 |
48,133,340 |
48,167,849 |
RGD:6480464 |
CTD |
| G |
KDM5A |
lysine (K)-specific demethylase 5A |
|
multiple interactions |
ISO |
12 |
389,223 |
498,620 |
RGD:6480464 |
CTD |
| G |
KIR3DL2 |
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 |
|
multiple interactions |
ISO |
19 |
55,361,898 |
55,378,670 |
RGD:6480464 |
CTD |
| G |
LCE3C |
late cornified envelope 3C |
|
decreases expression |
ISO |
1 |
152,573,138 |
152,573,562 |
RGD:6480464 |
CTD |
| G |
LDB3 |
LIM domain binding 3 |
|
increases expression |
ISO |
10 |
88,428,206 |
88,495,825 |
RGD:6480464 |
CTD |
| G |
MED13L |
mediator complex subunit 13-like |
|
affects expression |
ISO |
12 |
116,396,381 |
116,714,991 |
RGD:6480464 |
CTD |
| G |
MED13L |
mediator complex subunit 13-like |
|
decreases expression |
ISO |
12 |
116,396,381 |
116,714,991 |
RGD:6480464 |
CTD |
| G |
MLXIPL |
MLX interacting protein-like |
|
increases expression |
ISO |
7 |
73,007,524 |
73,038,870 |
RGD:6480464 |
CTD |
| G |
MMAB |
methylmalonic aciduria (cobalamin deficiency) cblB type |
|
affects expression |
ISO |
12 |
109,991,520 |
110,011,358 |
RGD:6480464 |
CTD |
| G |
MRPL33 |
mitochondrial ribosomal protein L33 |
|
multiple interactions |
ISO |
2 |
27,994,584 |
28,002,608 |
RGD:6480464 |
CTD |
| G |
MT-CO2 |
mitochondrially encoded cytochrome c oxidase II |
|
multiple interactions |
EXP |
MT |
7,586 |
8,269 |
RGD:6480464 |
CTD |
| G |
MT-CO2 |
mitochondrially encoded cytochrome c oxidase II |
|
decreases expression |
ISO |
MT |
7,586 |
8,269 |
RGD:6480464 |
CTD |
| G |
MT-COI |
mitochondrially encoded cytochrome c oxidase I |
|
decreases expression |
ISO |
MT |
5,904 |
7,445 |
RGD:6480464 |
CTD |
| G |
NDUFB3 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa |
|
increases expression |
ISO |
2 |
201,936,462 |
201,950,473 |
RGD:6480464 |
CTD |
| G |
NMRK1 |
nicotinamide riboside kinase 1 |
|
decreases expression |
EXP |
9 |
77,676,116 |
77,703,133 |
RGD:6480464 |
CTD |
| G |
PEO1 |
progressive external ophthalmoplegia 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
PHF11 |
PHD finger protein 11 |
|
multiple interactions |
ISO |
13 |
50,069,801 |
50,103,117 |
RGD:6480464 |
CTD |
| G |
PRDX1 |
peroxiredoxin 1 |
|
multiple interactions |
ISO |
1 |
45,976,707 |
45,988,562 |
RGD:6480464 |
CTD |
| G |
RASA3 |
RAS p21 protein activator 3 |
|
increases expression |
ISO |
13 |
114,747,194 |
114,898,095 |
RGD:6480464 |
CTD |
| G |
RNASE3 |
ribonuclease, RNase A family, 3 |
|
decreases expression |
ISO |
14 |
21,359,562 |
21,360,507 |
RGD:6480464 |
CTD |
| G |
RORA |
RAR-related orphan receptor A |
|
affects expression |
ISO |
15 |
60,780,483 |
61,521,502 |
RGD:6480464 |
CTD |
| G |
RORA |
RAR-related orphan receptor A |
|
decreases expression |
ISO |
15 |
60,780,483 |
61,521,502 |
RGD:6480464 |
CTD |
| G |
RPL17 |
ribosomal protein L17 |
|
multiple interactions |
ISO |
18 |
47,014,851 |
47,018,935 |
RGD:6480464 |
CTD |
| G |
SLC18B1 |
solute carrier family 18, subfamily B, member 1 |
|
decreases expression |
EXP |
6 |
133,090,507 |
133,119,747 |
RGD:6480464 |
CTD |
| G |
SLC25A36 |
solute carrier family 25 (pyrimidine nucleotide carrier ), member 36 |
|
affects expression |
ISO |
3 |
140,660,662 |
140,698,785 |
RGD:6480464 |
CTD |
| G |
SLC25A36 |
solute carrier family 25 (pyrimidine nucleotide carrier ), member 36 |
|
increases expression |
ISO |
3 |
140,660,662 |
140,698,785 |
RGD:6480464 |
CTD |
| G |
SMIM3 |
small integral membrane protein 3 |
|
decreases expression |
EXP |
5 |
150,157,508 |
150,176,298 |
RGD:6480464 |
CTD |
| G |
SNRNP200 |
small nuclear ribonucleoprotein 200kDa (U5) |
|
affects expression |
ISO |
2 |
96,940,074 |
96,971,307 |
RGD:6480464 |
CTD |
| G |
TMA16 |
translation machinery associated 16 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
4 |
164,415,673 |
164,441,691 |
RGD:6480464 |
CTD |
| G |
TMEM167B |
transmembrane protein 167B |
|
affects expression |
ISO |
1 |
109,633,403 |
109,639,554 |
RGD:6480464 |
CTD |
| G |
TMEM254 |
transmembrane protein 254 |
|
multiple interactions |
ISO |
10 |
81,838,402 |
81,852,307 |
RGD:6480464 |
CTD |
| G |
WBP1L |
WW domain binding protein 1-like |
|
increases expression |
EXP |
10 |
104,503,727 |
104,576,021 |
RGD:6480464 |
CTD |
| G |
YBX3 |
Y box binding protein 3 |
|
multiple interactions |
ISO |
12 |
10,851,676 |
10,875,953 |
RGD:6480464 |
CTD |
Term paths to the root
|